Form 10-Q - Quarterly report [Sections 13 or 15(d)]

ADUS Addus HomeCare Corp

ADUS Addus HomeCare Corp

Notizie Addus HomeCare Corp - ADUS

Notizie Addus HomeCare Corp - ADUS

La tua Cronologia

Più Attivi

Toplist

La tua Cronologia

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-34504

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)



Delaware		20-5340172
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

6303 Cowboys Way, Suite 600 Frisco, TX		75034
(Address of principal executive offices)		(Zip Code)

(469) 535-8200

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value	ADUS	The Nasdaq Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 30, 2024, Addus HomeCare Corporation had 16,370,336 shares of Common Stock outstanding.

Table of Contents

ADDUS HOMECARE CORPORATION

FORM 10-Q

INDEX


PART I. FINANCIAL INFORMATION	3

Item 1. Financial Statements (Unaudited)	3

Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023	3

Condensed Consolidated Statements of Income For the Three Months Ended March 31, 2024 and 2023	4

Condensed Consolidated Statement of Stockholders’ Equity For the Three Months Ended March 31, 2024 and 2023	5

Condensed Consolidated Statements of Cash Flows For the Three Months Ended March 31, 2024 and 2023	6

Notes to Condensed Consolidated Financial Statements	7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	17

Item 3. Quantitative and Qualitative Disclosures About Market Risk	30

Item 4. Controls and Procedures	30

PART II. OTHER INFORMATION	31

Item 1. Legal Proceedings	31

Item 1A. Risk Factors	31

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	31

Item 3. Defaults Upon Senior Securities	31

Item 4. Mine Safety Disclosures	31

Item 5. Other Information	31

Item 6. Exhibits	32

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

As of March 31, 2024 and December 31, 2023

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)



	March 31, 2024		December 31, 2023
Assets
Current assets
Cash	$	76,719	$	64,791
Accounts receivable, net of allowances		104,727		115,499
Prepaid expenses and other current assets		10,401		19,714
Total current assets		191,847		200,004
Property and equipment, net of accumulated depreciation and amortization		23,872		24,011
Other assets
Goodwill		663,391		662,995
Intangibles, net of accumulated amortization		90,191		91,983
Operating lease assets, net		44,699		45,433
Total other assets		798,281		800,411
Total assets	$	1,014,000	$	1,024,426
Liabilities and stockholders' equity
Current liabilities
Accounts payable	$	22,022	$	26,183
Accrued payroll		44,022		56,551
Accrued expenses		38,772		33,236
Operating lease liabilities, current portion		11,307		11,339
Government stimulus advances		13,548		5,765
Accrued workers' compensation insurance		11,920		12,043
Total current liabilities		141,591		145,117
Long-term liabilities
Long-term debt, less current portion, net of debt issuance costs		99,347		124,132
Long-term operating lease liabilities		39,044		39,711
Other long-term liabilities		8,875		8,772
Total long-term liabilities		147,266		172,615
Total liabilities	$	288,857	$	317,732
Stockholders' equity
Common stock—$.001 par value; 40,000 authorized and 16,370 and 16,227 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	$	16	$	16
Additional paid-in capital		406,465		403,846
Retained earnings		318,662		302,832
Total stockholders' equity		725,143		706,694
Total liabilities and stockholders' equity	$	1,014,000	$	1,024,426

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

For the Three Months Ended March 31, 2024 and 2023

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)


	For the Three Months Ended March 31,
	2024			2023
Net service revenues	$	280,746		$	251,599
Cost of service revenues		192,569			173,184
Gross profit		88,177			78,415
General and administrative expenses		61,063			56,360
Depreciation and amortization		3,469			3,447
Total operating expenses		64,532			59,807
Operating income		23,645			18,608
Interest income		(423	)		(106	)
Interest expense		2,758			2,461
Total interest expense, net		2,335			2,355
Income before income taxes		21,310			16,253
Income tax expense		5,480			3,578
Net income	$	15,830		$	12,675
Net income per common share
Basic income per share	$	0.99		$	0.79
Diluted income per share	$	0.97		$	0.78
Weighted average number of common shares and potential common shares outstanding:
Basic		16,063			15,949
Diluted		16,373			16,297

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the Three Months Ended March 31, 2024 and 2023

(Amounts and Shares in Thousands)

(Unaudited)


	For the Three Months Ended March 31, 2024
	Common Stock				Additional Paid-in		Retained		Total Stockholders'
	Shares		Amount		Capital		Earnings		Equity
Balance at January 1, 2024		16,227	$	16	$	403,846	$	302,832	$	706,694
Issuance of shares of common stock under restricted stock award agreements		143		—		—		—		—
Stock-based compensation		—		—		2,619		—		2,619
Shares issued for exercise of stock options		—		—		—		—		—
Net income		—		—		—		15,830		15,830
Balance at March 31, 2024		16,370	$	16	$	406,465	$	318,662	$	725,143

	For the Three Months Ended March 31, 2023
	Common Stock				Additional Paid-in		Retained		Total Stockholders'
	Shares		Amount		Capital		Earnings		Equity
Balance at January 1, 2023		16,128	$	16	$	393,208	$	240,316	$	633,540
Issuance of shares of common stock under restricted stock award agreements		76		—		—		—		—
Stock-based compensation		—		—		2,646		—		2,646
Shares issued for exercise of stock options		—		—		25		—		25
Net income		—		—		—		12,675		12,675
Balance at March 31, 2023		16,204	$	16	$	395,879	$	252,991	$	648,886

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Three Months Ended March 31, 2024 and 2023

(Amounts in Thousands)

(Unaudited)


	For the Three Months
	Ended March 31,
	2024			2023
Cash flows from operating activities:
Net income	$	15,830		$	12,675
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:
Depreciation and amortization		3,469			3,447
Deferred income taxes		131			(72	)
Stock-based compensation		2,619			2,646
Amortization of debt issuance costs under the credit facility		215			215
Provision for credit losses		224			144
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable		10,552			85
Prepaid expenses and other current assets		9,331			7,030
Government stimulus advances		7,783			(2,345	)
Accounts payable		(4,332	)		(494	)
Accrued payroll		(12,529	)		(10,901	)
Accrued expenses and other long-term liabilities		5,385			6,369
Net cash provided by operating activities		38,678			18,799
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired		(400	)		(965	)
Purchases of property and equipment		(1,350	)		(777	)
Net cash used in investing activities		(1,750	)		(1,742	)
Cash flows from financing activities:
Payments on revolver — credit facility		(25,000	)		(23,500	)
Cash received from exercise of stock options		—			25
Net cash (used in) provided by financing activities		(25,000	)		(23,475	)
Net change in cash		11,928			(6,418	)
Cash, at beginning of period		64,791			79,961
Cash, at end of period	$	76,719		$	73,543
Supplemental disclosures of cash flow information:
Cash paid for interest	$	2,527		$	2,310
Cash paid (refunded) for income taxes	$	13		$	(39	)

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us” or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care services segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy. The Company’s payors include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals.

Basis of Presentation

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2023 has been derived from the Company’s audited financial statements for the year ended December 31, 2023 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2023 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

Principles of Consolidation

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

2. Summary of Significant Accounting Policies

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, goodwill and intangibles in business combinations and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

Table of Contents

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:


	For the Three Months Ended March 31,
	(Amounts in thousands)
	2024		2023
Weighted average number of shares outstanding for basic per share calculation		16,063		15,949
Effect of dilutive potential shares:
Stock options		227		251
Restricted stock awards		83		97
Adjusted weighted average shares for diluted per share calculation		16,373		16,297
Anti-dilutive shares:
Stock options		61		61
Restricted stock awards		—		—

Recently Adopted Accounting Pronouncements

In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805). This ASU requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities (deferred revenue) from acquired contracts using the revenue recognition guidance in Topic 606. At the acquisition date, the acquirer applies the revenue model as if it had originated the acquired contracts. The ASU was adopted prospectively on January 1, 2023. The additional disclosures required did not have a material impact on our consolidated financial statements.

Recently Issued Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures, which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require, among other things, disclosure of significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”) and a description of other segment items (the difference between segment revenue less the segment expenses disclosed under the significant expense principle and each reported measure of segment profit or loss) by reportable segment, as well as disclosure of the title and position of the CODM, and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Annual disclosures are required for fiscal years beginning after December 15, 2023 and interim disclosures are required for periods within fiscal years beginning after December 15, 2024. Retrospective application is required, and early adoption is permitted. These requirements will result in expanded disclosures.

In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, may be applied prospectively or retrospectively, and allows for early adoption. These requirements are not expected to have an impact on the Company's financial statements and will expand income tax disclosures.

3. Leases

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:


	March 31, 2024		December 31, 2023
	(Amounts in Thousands)
Operating lease assets, net	$	44,699	$	45,433

Short-term operating lease liabilities (in accrued expenses)		11,307		11,339
Long-term operating lease liabilities		39,044		39,711
Total operating lease liabilities	$	50,351	$	51,050

Table of Contents

Lease Costs

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:


	For the Three Months Ended March 31, (Amounts in Thousands)
	2024			2023
Operating lease costs	$	3,296		$	3,042
Short-term lease costs		201			416
Total lease costs		3,497			3,458
Less: sublease income		(598	)		(700	)
Total lease costs, net	$	2,899		$	2,758

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:


	March 31, 2024			December 31, 2023
Operating leases:
Weighted average remaining lease term		6.11			6.26
Weighted average discount rate		5.64	%		5.47	%

Maturity of Lease Liabilities

Remaining operating lease payments as of March 31, 2024 were as follows:


	Operating Leases
	(Amounts in Thousands)
Due in the 12-month period ended March 31,
2025	$	10,663
2026		11,299
2027		8,959
2028		6,493
2029		5,496
Thereafter		17,390
Total future minimum rental commitments		60,300
Less: Imputed interest		(9,949	)
Total lease liabilities	$	50,351

Supplemental cash flows information


	For the Three Months Ended March 31,
	(Amounts in Thousands)
	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	3,589	$	3,374

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	2,137	$	10,836

Table of Contents

4. Goodwill and Intangible Assets

A summary of the goodwill and related adjustments is provided below:


	Hospice			Personal Care		Home Health		Total
	(Amounts in Thousands)
Goodwill as of December 31, 2023	$	432,799		$	153,276	$	76,920	$	662,995
Additions for acquisition		—			400		—		400
Adjustments to previously recorded goodwill		(54	)		—		50		(4	)
Goodwill as of March 31, 2024	$	432,745		$	153,676	$	76,970	$	663,391

On March 9, 2024, the Company completed its acquisition of the operations of Upstate Home Care Solutions (“Upstate”) for $0.4 million. With the purchase of Upstate, the Company expanded its personal care services segment in South Carolina. In connection with the Upstate acquisition, the Company recognized goodwill in its personal care segment of $0.4 million during the three months ended March 31, 2024.

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from one to twenty years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from five to ten years.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:


		March 31, 2024							December 31, 2023
		(Amounts in Thousands)							(Amounts in Thousands)
	Estimated Useful Life	Gross carrying value		Accumulated amortization			Net carrying value		Gross carrying value		Accumulated amortization			Net carrying value
Customer and referral relationships	5-10 years	$	44,672	$	(39,907	)	$	4,765	$	44,672	$	(39,566	)	$	5,106
Trade names and trademarks	1-20 years		59,566		(24,608	)		34,958		59,566		(23,857	)		35,709
Non-competition agreement	3-5 years		6,785		(5,805	)		980		6,785		(5,601	)		1,184
State Licenses	6-10 years		12,671		(9,511	)		3,160		12,671		(9,015	)		3,656
State Licenses	Indefinite		46,328		—			46,328		46,328		—			46,328
Total intangible assets		$	170,022	$	(79,831	)	$	90,191	$	170,022	$	(78,039	)	$	91,983

Amortization expense related to the intangible assets was $1.8 million and $1.7 million for the three months ended March 31, 2024 and 2023, respectively. The weighted average remaining useful lives of identifiable intangible assets as of March 31, 2024 was 10.14 years.

5. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:


	March 31, 2024		December 31, 2023
	(Amounts in Thousands)
Prepaid payroll	$	—	$	8,735
Prepaid workers' compensation and liability insurance		2,329		3,696
Prepaid licensing fees		5,651		4,481
Workers' compensation insurance receivable		699		577
Other		1,722		2,225
Total prepaid expenses and other current assets	$	10,401	$	19,714

Table of Contents

Accrued expenses consisted of the following:


	March 31, 2024		December 31, 2023
	(Amounts in Thousands)

Accrued health benefits		7,297		7,400
Payor advances (1)		429		1,218
Accrued professional fees		9,112		7,304
Accrued payroll and other taxes		13,013		8,572
Other		8,921		8,742
Total accrued expenses	$	38,772	$	33,236

(1)

Represents the deferred portion of payments received from payors for COVID-19 reimbursements which will be recognized as we incur specific COVID-19 related expenses (including expenses related to securing and maintaining adequate personnel) or will be returned to the extent such related expenses are not incurred.

6. Government Actions to Mitigate COVID-19’s Impact

The acute phase of the COVID-19 pandemic has faded, but the future course of COVID-19 remains uncertain. We will continue to closely monitor the impact of COVID-19 on all aspects of our business, including the impacts to our employees, patients and suppliers.

In recognition of the significant threat to the liquidity of financial markets posed by the COVID-19 pandemic, the Federal Reserve and Congress took dramatic actions to provide liquidity to businesses and the banking system in the United States, including relief for healthcare providers in the Coronavirus Aid, Relief, and Economic Stability Act (“CARES Act”), which was expanded by the Paycheck Protection Program and Health Care Enhancement (“PPPHCE”) Act, and the Consolidated Appropriations Act, 2021 (“CAA”), as well as the American Rescue Plan Act of 2021 (“ARPA”).

ARPA Spending Plans

The ARPA provides for $350 billion in relief funding for eligible state, local, territorial, and Tribal governments to mitigate the fiscal effects of the COVID-19 public health emergency. Additionally, the law provided for a 10 percentage point increase in federal matching funds for Medicaid home and community-based services (“HCBS”) from April 1, 2021, through March 31, 2022, provided the state satisfied certain conditions. States are permitted to use the state funds equivalent to the additional federal funds through March 31, 2025. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating

include those aimed at strengthening the provider workforce (e.g., efforts to recruit, retain, and train direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses.

During the three months ended March 31, 2024, the Company received additional state funding provided by the ARPA in an aggregate

amount of $10.2 million. The Company did not record revenue and related costs of service revenue during the three months ended March 31, 2024, because revenue recognition criteria were not met. Instead, the Company deferred recognition of the entire $10.2 million, which was received from states with specific spending plans and reporting requirements. Of the total state funding received by the Company pursuant to the ARPA through March 31, 2024, the Company utilized $2.4 million during the three months ended March 31, 2024, primarily for caregivers and adding support to recruiting and retention efforts, included as a reduction of cost of service revenues in the Company’s Unaudited Condensed Consolidated Statements of Income. As of March 31, 2024, the deferred portion of ARPA funding of $13.5 million is included within Government stimulus advances on the Company’s Unaudited Condensed Consolidated Balance Sheets.

Medicare Sequester

The CARES Act and related legislation also include other provisions offering financial relief, including, for example, temporarily suspending the Medicare sequester, which would have otherwise reduced payments to Medicare providers by 2% as required by the Budget Control Act of 2011. The sequestration adjustment resumed with a 1% reduction beginning April 1, 2022, and a 2% reduction beginning July 1, 2022. These sequestration cuts have been extended through April 2032.

Table of Contents

The ARPA increased the federal budget deficit in a manner that triggers an additional statutorily mandated sequestration under the PAYGO Act. As a result, an additional Medicare payment reduction of up to 4% was required to take effect in January 2022. However, Congress has delayed implementation of this payment reduction until 2025.

7. Long-Term Debt

Long-term debt consisted of the following:


	March 31, 2024			December 31, 2023
	(Amounts in Thousands)
Revolving loan under the credit facility	$	101,353		$	126,353
Less unamortized issuance costs		(2,006	)		(2,221	)
Long-term debt	$	99,347		$	124,132

Amended and Restated Senior Secured Credit Facility

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders, as amended by the First Amendment to Amended and Restated Credit Agreement, dated as of September 12, 2019, as further amended by the Second Amendment to Amended and Restated Credit Agreement, dated as of July 30, 2021, and as further amended by the Third Amendment to Amended and Restated Credit Agreement, dated as of April 26, 2023 (as described below, the “Third Amendment”) (as amended, the “Credit Agreement”, as used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement). The credit facility consists of a $600.0 million revolving credit facility and a $125.0 million incremental loan facility, which incremental loan facility may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2026.

On April 26, 2023, the Company entered into the Third Amendment to replace LIBOR with the Secured Overnight Financing Rate (“SOFR”) as the benchmark reference rate for loans under its credit facility. The Third Amendment did not amend any other terms of the Credit Agreement. The transition to SOFR did not and is not expected to have a material impact on the Company’s results of operations or liquidity.

Interest on the credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50% and (c) the sum of Term SOFR (as published by the CME Group Benchmark Administrative Limited) for an interest period of one month for such applicable day plus 0.10% (not to be less than 0.00%), plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the rate per annum equal to the sum of Term SOFR (as published by the CME Group Benchmark Administrative Limited) for the applicable interest period plus 0.10% (not to be less than zero). Swing loans may not be SOFR loans.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions and dispositions of assets. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters.

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility.

Table of Contents

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement), a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum permitted amount of capital expenditures. The Credit Agreement also contains restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $7.5 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement) thresholds, restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business.

During the three months ended March 31, 2024, the Company did not draw on its credit facility and repaid $25.0 million under the revolving credit facility.

At March 31, 2024, the Company had a total of $101.4 million of revolving loans, with an interest rate of 7.18%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $8.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $486.9 of capacity and $377.5 million available for borrowing under its credit facility. As of December 31, 2023, the Company had a total of $126.4 million of revolving loans, with an interest rate of 7.21%, outstanding on its credit facility.

As of March 31, 2024, the Company was in compliance with all financial covenants under the Credit Agreement.

8. Income Taxes

The effective income tax rates were 25.7% and 22.0% for the three months ended March 31, 2024 and 2023, respectively.

For the three months ended March 31, 2024, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes and non-deductible compensation, partially offset by the use of federal employment tax credits and excess tax benefit. For the three months ended March 31, 2024 and 2023, the effective tax rates were inclusive of an excess tax benefit of 0.1% and 1.2%, respectively. The excess tax expense or benefit is a discrete item, related to the vesting of equity shares, which requires the Company to recognize the expense or benefit fully in the period. An excess tax expense results if the Company’s cumulative costs of the award recognized exceed the income tax deduction, whereas an excess tax benefit results if the Company’s cumulative costs of the award recognized are less than the income tax deduction.

9. Commitments and Contingencies

Legal Proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.

It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

Table of Contents

10. Segment Information

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s chief operating decision makers, to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three distinct but related business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy.

The tables below set forth information about the Company’s reportable segments, along with the items necessary to reconcile the segment information to the totals reported in the accompanying Unaudited Condensed Consolidated Financial Statements. Segment assets are not reviewed by the Company’s chief operating decision maker function and therefore are not disclosed below.

Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.


	For the Three Months Ended March 31, 2024
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	208,003	$	55,863	$	16,880	$	280,746
Cost of services revenues		152,536		28,967		11,066		192,569
Gross profit		55,467		26,896		5,814		88,177
General and administrative expenses		15,445		13,439		4,537		33,421
Segment operating income	$	40,022	$	13,457	$	1,277		54,756


	For the Three Months Ended March 31, 2023
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	190,032	$	49,082	$	12,485	$	251,599
Cost of services revenues		138,383		27,267		7,534		173,184
Gross profit		51,649		21,815		4,951		78,415
General and administrative expenses		15,935		13,015		2,879		31,829
Segment operating income	$	35,714	$	8,800	$	2,072	$	46,586


	For the Three Months Ended March 31,
	2024			2023
	(Amounts in Thousands)
Segment reconciliation:
Total segment operating income	$	54,756		$	46,586

Items not allocated at segment level:
Other general and administrative expenses		27,642			24,531
Depreciation and amortization		3,469			3,447
Interest income		(423	)		(106	)
Interest expense		2,758			2,461
Income before income taxes	$	21,310		$	16,253

Table of Contents

11. Significant Payors

The Company’s revenue by payor type was as follows:



Personal Care Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
State, local and other governmental programs	$107,754	51.8	%	$95,320	50.1	%
Managed care organizations	94,276	45.3		87,901	46.3
Private pay	3,906	1.9		4,226	2.2
Commercial insurance	1,486	0.7		1,669	0.9
Other	581	0.3		916	0.5
Total personal care segment net service revenues	$208,003	100.0	%	$190,032	100.0	%



Hospice Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Medicare	$50,652	90.7	%	$44,556	90.7	%
Commercial insurance	3,134	5.6		2,547	5.2
Managed care organizations	1,817	3.3		1,647	3.4
Other	260	0.4		332	0.7
Total hospice segment net service revenues	$55,863	100.0	%	$49,082	100.0	%



Home Health Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Medicare	$11,663	69.1	%	$9,270	74.2	%
Managed care organizations	4,400	26.1		2,539	20.3
Other	817	4.8		676	5.5
Total home health segment net service revenues	$16,880	100.0	%	$12,485	100.0	%

The Company derives a significant amount of its revenue from its operations in Illinois, New Mexico, New York and Ohio. The percentages of segment revenue for each of these significant states were as follows:



Personal Care Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Illinois	$107,575	51.8	%	$98,414	51.8	%
New Mexico	28,967	13.9		28,474	15.0
New York(1)	23,534	11.3		21,885	11.5
All other states	47,927	23.0		41,259	21.7
Total personal care segment net service revenues	$208,003	100.0	%	$190,032	100.0	%

Table of Contents

(1)

In 2019, New York initiated a new Request For Offer (“RFO”) process to competitively procure Consumer Directed Personal Assistance Program (“CDPAP”) fiscal intermediaries. The Company was not one of the entities selected to enter into contracts as a Lead Fiscal Intermediary through the initial RFO process. However, the New York legislature intervened in 2022, authorizing fiscal intermediary applicants who satisfied certain criteria to continue operating in all counties contained in their RFO application. Although the Company was permitted to continue its CDPAP fiscal intermediary operations, the Company decided in November 2022 to suspend materially all of its new fee-for-service patient admissions through County Social Service Departments in the CDPAP. On June 6, 2023, the New York State Department of Health (“NYSDOH”) notified the Company that it had received a contract award. Under this contract, the Company is providing services to all current payors and has resumed new fee-for-service patient admissions through County Social Service Departments in the CDPAP. The CDPAP continues to be a focus for changes by New York governmental authorities. For example, the New York fiscal year 2025 budget will replace the CDPAP fiscal intermediaries with a single statewide fiscal intermediary with a stated deadline of April 1, 2025. The statewide fiscal intermediary, which will be selected by the NYSDOH, will be able to subcontract with several entities to facilitate the delivery of fiscal intermediary services. All service providers seeking to offer services under CDPAP will be required to contract with the statewide fiscal intermediary or its contractors in order to offer services. The Company does not currently believe it is likely to be selected as the single statewide fiscal intermediary and it is not possible at this time to assess the likelihood of becoming a subcontractor or the financial terms of any such arrangement. At this time, it is difficult to predict the details of the implementation of these modifications and their final timeline and, thus, their impact on the Company’s business and operations. However, we expect this could have a negative impact on our New York CDPAP business, though it would not be material to our business as a whole.



Hospice Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Ohio	$20,236	36.2	%	$18,451	37.6	%
Illinois	12,252	21.9		11,480	23.4
New Mexico	7,515	13.5		6,486	13.2
All other states	15,860	28.4		12,665	25.8
Total hospice segment net service revenues	$55,863	100.0	%	$49,082	100.0	%



Home Health Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
New Mexico	$7,777	46.1	%	$9,116	73.0	%
Illinois	2,942	17.4		3,369	27.0
Tennessee	6,161	36.5		—	—
Total home health segment net service revenues	$16,880	100.0	%	$12,485	100.0	%

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state and local governmental agencies. The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 38.3% and 39.1% of our net service revenues for the three months ended March 31, 2024 and 2023, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 20.8% and 21.5% of the Company’s net service revenues for the three months ended March 31, 2024 and 2023, respectively.

The related receivables due from the Illinois Department on Aging represented 18.0% and 20.7% of the Company’s net accounts receivable at March 31, 2024 and December 31, 2023, respectively.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements about our business and operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words like “believes,” “belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “would,” “should” and similar expressions are intended to be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the impact of macroeconomic conditions, including significant global inflation and elevated interest rates, legislative developments, trade disruptions and the potential adverse effects of current geopolitical conditions; business disruptions due to natural disasters, acts of terrorism, pandemics, riots, civil insurrection or social unrest, looting, protests, strikes or street demonstrations; changes in operational and reimbursement processes and payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations policies and payment rates, and the timeliness of reimbursements received under government programs; changes in, or our failure to comply with, existing, federal and state laws or regulations, or our failure to comply with new government laws or regulations on a timely basis; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and retain qualified personnel; federal, state and city minimum wage pressure, including any failure of any governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to the overall economic conditions and deficit reduction measures by federal and state governments, and our expectations regarding these changes; cost containment initiatives undertaken by federal and state governmental and other third-party payors; our ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; our ability to integrate and manage our information systems; any security breaches, cyber-attacks, loss of data, or cybersecurity threats or incidents, and any actual or perceived failures to comply with legal requirements related to the privacy of confidential consumer data and other sensitive information; the size and growth of the markets for our services, including our expectations regarding the markets for our services; eligibility standards and limits on services imposed by state governmental agencies; the potential for litigation, audits and investigations; discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating and integrating acquisition opportunities and expand into new geographic markets; the impact of acquisitions and dispositions on our business, including the potential inability to realize the benefits of potential acquisitions; the effectiveness, quality and cost of our services; our ability to successfully execute our growth strategy; changes in tax rates; the impact of inclement weather or natural disasters; and various other matters, many of which are beyond our control. In addition, these forward-looking statements are subject to the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2023, filed with the SEC on February 27, 2024. You should carefully review all of these factors. Moreover, our business may be materially adversely affected by factors that are not currently known to us, by factors that we currently consider immaterial or by factors that are not specific to us, such as general economic conditions. These forward-looking statements were based on information, plans and estimates at the date of this report, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes, except as may be required by law.

Overview

We are a home care services provider operating three segments: personal care, hospice and home health. Our services are principally provided in-home under agreements with federal, state and local government agencies, managed care organizations, commercial insurers and private individuals. Our consumers are predominantly “dual eligible,” meaning they are eligible to receive both Medicare and Medicaid benefits. Managed care organizations accounted for 35.8% and 36.6% of our net service revenues during the three months ended March 31, 2024 and 2023, respectively.

A summary of certain consolidated financial results is provided in the table below.


	For the Three Months Ended March 31,
	2024		2023
Net service revenues by segment:	(Amounts in Thousands)
Personal care	$	208,003	$	190,032
Hospice		55,863		49,082
Home health		16,880		12,485
Total net service revenue	$	280,746	$	251,599

Net income	$	15,830	$	12,675

Table of Contents

As of March 31, 2024, we provided our services in 22 states through 214 offices. We served approximately 57,000 and 55,000 discrete individuals, respectively, during the three months ended March 31, 2024 and 2023. Our personal care segment also includes staffing services, with clients including assisted living facilities, nursing homes and hospice facilities.

Acquisitions

In addition to our organic growth, we have grown through acquisitions that have expanded our presence in current markets, with the goal of having all three levels of in-home care in our markets or facilitating our entry into new markets where in-home care has been moving to managed care organizations or that present other strategic opportunities.

On January 1, 2023, we completed the acquisition of CareStaff for approximately $1.0 million, with funding provided by available cash. With the purchase of CareStaff, the Company expanded its personal care services in Florida.

On August 1, 2023, we completed the acquisition of Tennessee Quality Care for approximately $111.2 million, with funding primarily provided by drawing on the Company’s revolving credit facility. The purchase price is subject to the completion of working capital and related adjustments. With the purchase of Tennessee Quality Care, the Company expanded its services within its hospice and home health segment to Tennessee.

On March 9, 2024, we completed our acquisition of the operations of Upstate for $0.4 million, with funding provided by available cash. With the purchase of Upstate, the Company expanded its personal care services segment in South Carolina.

Recruiting

As the labor market continues to be tight and unemployment remains at low levels, the competition for new caregivers, including skilled healthcare staff, and support staff continues to be significant. In addition, the United States economy continues to experience significant inflationary pressures and a competitive labor market. To the extent that we continue to experience a shortage of caregivers, it may hinder our ability to fully meet the continuing demand for both our non-clinical and clinical services.

Revenue by Payor and Significant States

Our payors are principally federal, state and local governmental agencies and managed care organizations. The federal, state and local programs under which the agencies operate are subject to legislative and budgetary changes and other risks that can influence reimbursement rates. We are experiencing a transition of business from government payors to managed care organizations, which we believe aligns with our emphasis on coordinated care and the reduction of the need for acute care.

Our revenue by payor and significant states by segment were as follows:


Personal Care Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
State, local and other governmental programs	$107,754	51.8	%	$95,320	50.1	%
Managed care organizations	94,276	45.3		87,901	46.3
Private pay	3,906	1.9		4,226	2.2
Commercial insurance	1,486	0.7		1,669	0.9
Other	581	0.3		916	0.5
Total personal care segment net service revenues	$208,003	100.0	%	$190,032	100.0	%
Illinois	$107,575	51.8	%	$98,414	51.8	%
New Mexico	28,967	13.9		28,474	15.0
New York (1)	23,534	11.3		21,885	11.5
All other states	47,927	23.0		41,259	21.7
Total personal care segment net service revenues	$208,003	100.0	%	$190,032	100.0	%

Table of Contents

(1)

In 2019, New York initiated a new RFO process to competitively procure CDPAP fiscal intermediaries. The Company was not one of the entities selected to enter into contracts as a Lead Fiscal Intermediary through the initial RFO process. However, the New York legislature intervened in 2022, authorizing fiscal intermediary applicants who satisfied certain criteria to continue operating in all counties contained in their RFO application. Although the Company was permitted to continue its CDPAP fiscal intermediary operations, the Company decided in November 2022 to suspend materially all of its new fee-for-service patient admissions through County Social Service Departments in the CDPAP. On June 6, 2023, the NYSDOH notified the Company that it had received a contract award. Under this contract, the Company is providing services to all current payors and has resumed new fee-for-service patient admissions through County Social Service Departments in the CDPAP. The CDPAP continues to be a focus for changes by New York governmental authorities. For example, the New York fiscal year 2025 budget will replace the CDPAP fiscal intermediaries with a single statewide fiscal intermediary with a stated deadline of April 1, 2025. The statewide fiscal intermediary, which will be selected by the NYSDOH, will be able to subcontract with several entities to facilitate the delivery of fiscal intermediary services. All service providers seeking to offer services under CDPAP will be required to contract with the statewide fiscal intermediary or its contractors in order to offer services. The Company does not currently believe it is likely to be selected as the single statewide fiscal intermediary and it is not possible at this time to assess the likelihood of becoming a subcontractor or the financial terms of any such arrangement. At this time, it is difficult to predict the details of the implementation of these modifications and their final timeline and, thus, their impact on the Company’s business and operations. However, we expect this could have a negative impact on our New York CDPAP business, though it would not be material to our business as a whole.


Hospice Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Medicare	$50,652	90.7	%	$44,556	90.8	%
Commercial insurance	3,134	5.6		2,547	5.2
Managed care organizations	1,817	3.3		1,647	3.4
Other	260	0.4		332	0.6
Total hospice segment net service revenues	$55,863	100.0	%	$49,082	100.0	%
Ohio	$20,236	36.2	%	$18,451	37.6	%
Illinois	12,252	21.9		11,480	23.4
New Mexico	7,515	13.5		6,486	13.2
All other states	15,860	28.4		12,665	25.8
Total hospice segment net service revenues	$55,863	100.0	%	$49,082	100.0	%


Home Health Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Medicare	$11,663	69.1	%	$9,270	74.2	%
Managed care organizations	4,400	26.1		2,539	20.3
Other	817	4.8		676	5.5
Total home health segment net service revenues	$16,880	100.0	%	$12,485	100.0	%
New Mexico	$7,777	46.1	%	$9,116	73.0	%
Illinois	2,942	17.4		3,369	27.0
Tennessee	6,161	36.5		—	—
Total home health segment net service revenues	$16,880	100.0	%	$12,485	100.0	%

The personal care segment derives a significant amount of its net service revenues in Illinois, which represented 38.3% and 39.1% of our net service revenues for the three months ended March 31, 2024 and 2023, respectively.

Table of Contents

A significant amount of our net service revenues are derived from one payor, the Illinois Department on Aging, the largest payor program for our Illinois personal care operations, which accounted for 20.8% and 21.5% of our net service revenues for the three months ended March 31, 2024 and 2023, respectively.

Changes in Reimbursement Rates

Illinois

On November 26, 2019, the City of Chicago voted to approve additional increases in the Chicago minimum wage to $14 per hour beginning July 1, 2020 and to $15 per hour beginning July 1, 2021. In each subsequent year, the City is required to raise the wage based on increases in the Consumer Price Index (“CPI”) subject to a cap and other requirements. On July 1, 2023, the rate was adjusted to $15.80 based on the increase in the CPI.

The Illinois fiscal year 2023 budget included an increase of hourly rates for in-home care services to $25.66, to be effective January 1, 2023. This increase offsets the $0.40 increase in Chicago minimum wage that occurred on July 1, 2022. In addition, CMS approved a waiver amendment proposal submitted by the Illinois Department of Healthcare and Family Services with regard to its Persons who are Elderly program, further increasing in-home care rates to $26.92, effective March 1, 2023.

The Illinois fiscal year 2024 budget passed in June 2023 included an increase in hourly rates for in-home care services to $28.07, which took effect on January 1, 2024 and required a minimum wage rate of $17.00 per hour.

Our business will benefit from the rate increases noted above as planned for 2024, but there is no assurance that there will be additional offsetting rate increases in Illinois for fiscal years beyond fiscal year 2024, and our financial performance will be adversely impacted for any periods in which an additional offsetting reimbursement rate increase is not in effect.

Impact of Changes in Medicare and Medicaid Reimbursement

Hospice

Hospice services provided to Medicare beneficiaries are paid under the Medicare Hospice Prospective Payment System, under which CMS sets a daily rate for each day a patient is enrolled in the hospice benefit. CMS updates these rates each federal fiscal year. Effective October 1, 2023, CMS increased hospice payment rates by 3.1%. This reflects a 3.3% market basket increase and a negative 0.2 percentage point productivity adjustment. Hospices that do not satisfy quality reporting requirements will be subject to a 4-percentage point reduction to the market basket update.

Overall payments made by Medicare to each hospice provider number are subject to an inpatient cap and an aggregate cap, which is set each federal fiscal year. The inpatient cap limits the number of days of inpatient care to no more than 20% of total patient care days. The aggregate cap, which limits the total Medicare reimbursement that a hospice may receive based on an annual per-beneficiary cap amount and the number of Medicare patients served, was updated to $33,494.01 for federal fiscal year 2024. If a hospice’s Medicare payments exceed its inpatient or aggregate caps, it must repay Medicare the excess amount.

Home Health

Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System (“HHPPS”), which uses national, standardized 30-day period payment rates for periods of care that meet a certain threshold of home health visits (periods of care that do not meet the visit threshold are paid a per-visit payment rate for providing care). Although payment is made for each 30-day period, the HHPPS permits continuous 60-day certification periods through which beneficiaries are verified as eligible for the home health benefit. The daily home health payment rate is adjusted for case-mix and area wage levels. CMS uses the Patient-Driven Groupings Model (“PDGM”) as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics and their resource needs. An outlier adjustment may be paid for periods of care where costs exceed a specific threshold amount.

CMS updates the HHPPS payment rates each calendar year. For calendar year 2024, CMS estimates that Medicare payments to home health agencies will increase by 0.8%. This is based on a home health payment update percentage of 3.0, which reflects a 3.3% market basket update reduced by a productivity adjustment of negative 0.3 percentage points, and an estimated 2.6% decrease associated with the transition to the PDGM, among other changes. Home health providers that do not comply with quality data reporting requirements are subject to a 2-percentage point reduction to their market basket update. In addition, Medicare requires home health agencies to submit a one-time Notice of Admission (“NOA”) for each patient that establishes that the beneficiary is under a Medicare home health period of care. Failure to submit the NOA within five calendar days from the start of care will result in a reduction to the 30-day period payment amount for each day from the start of care date until the date the NOA is submitted.

Table of Contents

CMS began implementing a nationwide expansion of the Home Health Value-Based Purchasing (“HHVBP”) Model in 2022. Under the HHVBP Model, home health agencies receive increases or decreases to their Medicare fee-for-service payments of up to 5% based on performance against specific quality measures relative to the performance of other home health providers. Data collected in each performance year will impact Medicare payments two years later. Calendar year 2023 was the first performance year under the expanded HHVBP Model, which will affect payments in calendar year 2025.

In certain states, payment of claims may be impacted by the Review Choice Demonstration for Home Health Services, a program intended to identify and prevent fraud, reduce the number of Medicare appeals and improve provider compliance with Medicare program requirements. The program currently applies to home health agencies in certain states, including Illinois, Ohio, Oklahoma, North Carolina, Florida and Texas. Providers in states subject to the Review Choice Demonstration may initially select from the following claims review and approval processes: pre-claim review, post-payment review or a minimal post-payment review with a 25% payment reduction. Home health agencies that maintain high compliance levels will be eligible for additional options that may be less burdensome. This program has not had a material impact on our results of operations or financial position.

The IMPACT Act required the Department of Health and Human Services (“HHS”), together with the Medicare Payment Advisory Commission (“MedPAC”), to consider and propose a unified payment system for post-acute care services provided by home health agencies, inpatient rehabilitation facilities, skilled nursing facilities, and long-term care hospitals. A unified post-acute care payment system would pay post-acute care providers under a single framework according to a patient’s characteristics, rather than based on the post-acute care setting where the patient receives treatment. As required under the statute, CMS and the HHS Office of the Assistant Secretary for Planning and Evaluation issued a report in July 2022 presenting a prototype for a unified post-acute care payment model, and MedPAC submitted a report to Congress in June 2023 evaluating a prototype design. Although both CMS and MedPAC concluded that designing a unified payment system is feasible, CMS noted that universal implementation of a unified payment system would require congressional action and MedPAC cautioned that implementation would be complex. Due to the agency resources required to implement a unified model, MedPAC noted that CMS may consider smaller-scale site-neutral policies to address some of the overlap in patients treated in different settings and highlighted that recent changes to various post-acute care payment systems address some of the concerns underlying the push for a unified model.

New York Consumer Directed Personal Assistance Program (“CDPAP”)

The CDPAP is a self-directed care alternative program that allows eligible individuals who need help with activities of daily living or skilled nursing services to choose their caregivers. We provide support services as a CDPAP fiscal intermediary. The Company recognized approximately $10.4 million and $10.1 million in revenue from the program for the three months ended March 31, 2024 and 2023, respectively.

In 2019, New York initiated a new RFO process to competitively procure CDPAP fiscal intermediaries. The Company was not one of the entities selected to enter into contracts as a Lead Fiscal Intermediary through the initial RFO process. However, the New York legislature intervened in 2022, authorizing fiscal intermediary applicants who satisfied certain criteria to continue operating in all counties contained in their RFO application. Although the Company was permitted to continue its CDPAP fiscal intermediary operations, the Company decided in November 2022 to suspend materially all of its new fee-for-service patient admissions through County Social Service Departments in the CDPAP. On June 6, 2023, the NYSDOH notified the Company that it had received a contract award. Under this contract, the Company is providing services to all current payors and has resumed new fee-for-service patient admissions through County Social Service Departments in the CDPAP. The CDPAP continues to be a focus for changes by New York governmental authorities. For example, the New York fiscal year 2025 budget, which was signed by the governor on April 20, 2024, will replace the CDPAP fiscal intermediaries with a single statewide fiscal intermediary with a stated deadline of April 1, 2025. The statewide fiscal intermediary, which will be selected by the NYSDOH, will be able to subcontract with several entities to facilitate the delivery of fiscal intermediary services. All service providers seeking to offer services under CDPAP will be required to contract with the statewide fiscal intermediary or its contractors in order to offer services. The Company does not currently believe it is likely to be selected as the single statewide fiscal intermediary and it is not possible at this time to assess the likelihood of becoming a subcontractor or the financial terms of any such arrangement. At this time, it is difficult to predict the details of the implementation of these modifications and their final timeline and, thus, their impact on the Company’s business and operations. However, we expect this could have a negative impact on our New York CDPAP business, though it would not be material to our business as a whole.

Table of Contents

CMS Final Rule: “Ensuring Access to Medicaid Services”

On April 22, 2024, CMS announced a final rule intended to improve access to services and quality of care for Medicaid beneficiaries across fee-for-service and managed care delivery systems. The final rule includes significant provisions related to HCBS, including the “80/20” or “payment adequacy” requirement, which will require states to ensure that at least 80% of all Medicaid payments a provider receives for homemaker, home health aide, and personal care services, less certain excluded costs, under certain programs are spent on total compensation (including benefits) for direct care workers furnishing these services, rather than administrative overhead or profit, subject to limited exceptions. States are required to ensure compliance with the 80/20 requirement by mid-2030. The final rule made a number of technical changes to the definitions used in calculating compliance that clarified or narrowed the revenue covered by the calculation and clarified or expanded the payments to workers that are counted in satisfying the requirement, which combined to make compliance less onerous to providers.

The final rule includes several other measures intended to promote transparency and enhance quality and access to services, including a variety of reporting requirements for States. Given the very long implementation period and the likelihood of further changes as a result of litigation, administration changes, further rule-making and state changes in response to the final rule, it is premature to predict the ultimate impact of the final rule on our business.

Components of our Statements of Income

Net Service Revenues

We generate net service revenues by providing our services directly to consumers and primarily on an hourly basis in our personal care segment, on a daily basis in our hospice segment and on an episodic basis in our home health segment. We receive payment for providing such services from our private consumers and payors, including federal, state and local governmental agencies, managed care organizations and commercial insurers.

In our personal care segment, net service revenues are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate, which is either contractual or fixed by legislation, and are recognized at the time services are rendered. In our hospice segment, net service revenues are provided based on daily rates for each of the levels of care and are recognized as services are provided. In our home health segment, net service revenues are based on an episodic basis at a stated rate and recognized based on the number of days elapsed during a period of care within the reporting period. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record revenues.

Cost of Service Revenues

We incur direct care wages, payroll taxes and benefit-related costs in connection with providing our services. We also provide workers’ compensation and general liability coverage for our employees. Employees are also reimbursed for their travel time and related travel costs in certain instances.

General and Administrative Expenses

Our general and administrative expenses include our costs for operating our network of local agencies and our administrative offices. Our agency expenses consist of costs for supervisory personnel, our community care supervisors and office administrative costs. Personnel costs include wages, payroll taxes and employee benefits. Facility costs include rents, utilities, and postage, telephone and office expenses. Our corporate and support center expenses include costs for accounting, information systems, human resources, billing and collections, contracting, marketing and executive leadership. These expenses consist of compensation, including stock-based compensation, payroll taxes, employee benefits, legal, accounting and other professional fees, travel, general insurance, rents, provision for doubtful accounts and related facility costs. Expenses related to streamlining our operations such as costs related to terminated employees, termination of professional services relationships, other contract termination costs and asset write-offs are also included in general and administrative expenses.

Depreciation and Amortization Expenses

Depreciable assets consist principally of furniture and equipment, network administration and telephone equipment and operating system software. Depreciable and leasehold assets are depreciated or amortized on a straight-line method over their useful lives or, if less and if applicable, their lease terms. We amortize our intangible assets with finite lives, consisting of customer and referral relationships, trade names, trademarks and non-competition agreements, using straight line or accelerated methods based upon their estimated useful lives.

Table of Contents

Interest Expense

Interest expense is reported when incurred and principally consists of interest and unused credit line fees on the credit facility.

Income Tax Expense

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 25.7% and 22.0% for the three months ended March 31, 2024 and 2023, respectively, compared to our federal statutory rate of 21%. The difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes, non-deductible compensation, excess tax expense/benefit and the use of federal employment tax credits.

Results of Operations — Consolidated

Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023

The following table sets forth our unaudited condensed consolidated results of operations.


		For the Three Months Ended March 31,
		2024							2023							Change
					% Of							% Of
					Net Service							Net Service
		Amount			Revenues				Amount			Revenues				Amount			%
	(Amounts in Thousands, Except Percentages)
Net service revenues		$	280,746			100.0		%	$	251,599			100.0		%	$	29,147			11.6		%
Cost of service revenues			192,569			68.6				173,184			68.8				19,385			11.2
Gross profit			88,177			31.4				78,415			31.2				9,762			12.4
General and administrative expenses			61,063			21.8				56,360			22.4				4,703			8.3
Depreciation and amortization			3,469			1.2				3,447			1.4				22			0.6
Total operating expenses			64,532			23.0				59,807			23.8				4,725			7.9
Operating income			23,645			8.4				18,608			7.4				5,037			27.1
Interest income			(423	)		(0.2	)			(106	)		(0.0	)			(317	)		299.1
Interest expense			2,758			1.0				2,461			1.0				297			12.1
Total interest expense, net			2,335			0.8				2,355			0.9				(20	)		(0.8	)
Income before income taxes			21,310			7.6				16,253			6.5				5,057			31.1
Income tax expense			5,480			2.0				3,578			1.4				1,902			53.2
Net income		$	15,830			5.6		%	$	12,675			5.0		%	$	3,155			24.9		%

Net service revenues increased by 11.6% to $280.7 million for the three months ended March 31, 2024 compared to $251.6 million for the three months ended March 31, 2023. Revenue increased by $18.0 million in our personal care segment, $6.8 million in our hospice segment and by $4.4 million in our home health segment during the three months ended March 31, 2024, compared to the same period in 2023. The increase in our personal care segment was due to organic growth. The increase in our hospice and home health segment revenue was due to the acquisition of the operations of Tennessee Quality Care on August 1, 2023.

Gross profit, expressed as a percentage of net service revenues, increased to 31.4% for the three months ended March 31, 2024, compared to 31.2% for the same period in 2023 due to growth in our higher margin hospice segment.

General and administrative expenses increased to $61.1 million for the three months ended March 31, 2024, as compared to $56.4 million for the three months ended March 31, 2023. The increase in general and administrative expenses was primarily due to the Tennessee Quality Care acquisition that resulted in an increase in administrative employee wage, bonus, tax and benefit costs of $2.1 million and an increase in acquisition expense of $1.5 million. General and administrative expenses, expressed as a percentage of net service revenues, decreased to 21.8% for the three months ended March 31, 2024, from 22.4% for the three months ended March 31, 2023.

Interest expense increased to $2.8 million for the three months ended March 31, 2024 from $2.5 million for the three months ended March 31, 2023. The increase in interest expense was primarily due to increased interest rates under our credit facility for the three months ended March 31, 2024 compared to the three months ended March 31, 2023.

Table of Contents

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. The effective income tax rate was 25.7% and 22.0% for the three months ended March 31, 2024 and 2023, respectively. Our higher effective income tax rate for the three months ended March 31, 2024 was principally due to a lower excess tax benefit as well as a lower benefit from the use of federal employment tax credits. For the three months ended March 31, 2024 and 2023, the excess tax benefit and federal employment tax credits were 3.5% and 6.8%, respectively.

Results of Operations – Segments

The following tables and related analysis summarize our operating results and business metrics by segment:

Personal Care Segment


	For the Three Months Ended March 31,
	2024				2023				Change
	Amount		% of Segment Net Service Revenues		Amount		% of Segment Net Service Revenues		Amount	%
	(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$208,003		100.0	%	$190,032		100.0	%	$17,971	9.5	%
Cost of services revenues	152,536		73.3		138,383		72.8		14,153	10.2
Gross profit	55,467		26.7		51,649		27.2		3,818	7.4
General and administrative expenses	15,445		7.4		15,935		8.4		(490)	(3.1)
Segment operating income	$40,022		19.3	%	$35,714		18.8	%	$4,308	12.1	%
Business Metrics (Actual Numbers, Except Billable Hours in Thousands)
Locations at period end	153				157
Average billable census * (1)	37,715				38,363				(648)	(1.7)	%
Billable hours * (2)	7,590				7,592				(2)	-
Average billable hours per census per month * (2)	67.0				65.8				1.2	1.8
Billable hours per business day * (2)	116,769				116,805				(36)	-
Revenues per billable hour * (2)	$27.35				$24.98				$2.37	9.5	%
Same store growth revenue % * (3)	9.3	%			11.4	%

(1)

Average billable census is the number of unique clients receiving a billable service during the year and is the total census divided by months in operation during the period.

(2)

Billable hours is the total number of hours served to clients during the period. Average billable hours per census per month is billable hours divided by average billable census. Billable hours per day is total billable hours divided by the number of business days in the period. Revenues per billable hour is revenue, attributed to billable bonus hours, divided by billable hours.

(3)

Same store growth reflects the change in year-over-year revenue for the same store base. We define the same store base to include those stores open for at least 52 full weeks. This measure highlights the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures and ARPA associated revenue from this calculation.

* Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly titled performance indicators used by other companies.

The personal care segment derives a significant amount of its net service revenues from operations in Illinois, which represented 38.3% and 39.1% of our net service revenues for the three months ended March 31, 2024 and 2023, respectively. One payor, the Illinois Department on Aging, accounted for 20.8% and 21.5% of net service revenues for the three months ended March 31, 2024 and 2023, respectively.

Table of Contents

Net service revenues from state, local and other governmental programs accounted for 51.8% and 50.1% of net service revenues for the three months ended March 31, 2024 and 2023, respectively. Managed care organizations accounted for 45.3% and 46.3% of net service revenues for the three months ended March 31, 2024 and 2023, respectively, with commercial insurance, private pay and other payors accounting for the remainder of net service revenues.

Net service revenues increased by 9.5% for the three months ended March 31, 2024 compared to the three months ended March 31, 2023. Net service revenues included a 9.5% increase in revenues per billable hour for the three months ended March 31, 2024, mainly attributed to rate increases discussed above, as compared to the three months ended March 31, 2023. Gross profit, expressed as a percentage of net service revenues, decreased marginally to 26.7% for the three months ended March 31, 2024 from 27.2% for the three months ended March 31, 2023. This decrease was primarily due to increases in direct payroll and benefits expenses for the three months ended March 31, 2024.

The personal care segment’s general and administrative expenses primarily consist of administrative employee wages, taxes and benefit costs, rent, information technology and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 7.4% and 8.4% for the three months ended March 31, 2024 and 2023, respectively.

Hospice Segment


	For the Three Months Ended March 31,
	2024				2023				Change
	Amount		% of Segment Net Service Revenues		Amount		% of Segment Net Service Revenues		Amount	%
	(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$55,863		100.0	%	$49,082		100.0	%	$6,781	13.8	%
Cost of services revenues	28,967		51.9		27,267		55.6		1,700	6.2
Gross profit	26,896		48.1		21,815		44.4		5,081	23.3
General and administrative expenses	13,439		24.1		13,015		26.5		424	3.3
Segment operating income	$13,457		24.0	%	$8,800		17.9	%	$4,657	52.9	%
Business Metrics (Actual Numbers)
Locations at period end	38				33
Admissions * (1)	3,472				3,324				148	4.5	%
Average daily census * (2)	3,359				3,195				164	5.1
Average discharge length of stay * (3)	90				88				2	2.3
Patient days * (4)	305,630				287,551				18,079	6.3
Revenue per patient day * (5)	$182.78				$176.22				$6.56	3.7	%
Organic growth
- Revenue * (6)	5.8	%			2.6	%
- Average daily census * (6)	(1.1)	%			1.5	%

(1)

Represents referral process and new patients on service during the period.

(2)

Average daily census is total patient days divided by the number of days in the period.

(3)

Average length of stay is the average number of days a patient is on service, calculated upon discharge, and is total patient days divided by total discharges in the period.

(4)

Patient days is days of service for all patients in the period.

(5)

Revenue per patient day is hospice revenue divided by the number of patient days in the period.

(6)

Revenue organic growth and average daily census organic growth reflect the change in year-over-year revenue and average daily census for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures.

Table of Contents

Hospice generates revenue by providing care to patients with a life expectancy of six months or less, as well as related services for their families. Hospice offers four levels of care, as defined by Medicare, to meet the varying needs of patients and their families. The four levels of hospice include routine home care, continuous home care, general inpatient care and respite care. Our hospice segment principally provides routine home care.

Net service revenues from Medicare accounted for 90.7% for both the three months ended March 31, 2024 and 2023, respectively. Net service revenues from managed care organizations accounted for 3.3% and 3.4% for the three months ended March 31, 2024 and 2023, respectively.

Net service revenues increased by $6.8 million for the three months ended March 31, 2024 compared to the three months ended March 31, 2023, primarily attributed to organic growth and the acquisition of the operations of Tennessee Quality Care on August 1, 2023.

Gross profit, expressed as a percentage of net service revenues, was 48.1% and 44.4% for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024, the increase was mainly attributed to a decrease in direct employee wage, tax and benefit costs as a percentage of net service revenues.

The hospice segment’s general and administrative expenses primarily consist of administrative employee wage, tax and benefit costs, rent, information technology and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 24.1% and 26.5% for the three months ended March 31, 2024 and 2023, respectively. The decrease in general and administrative expenses as a percentage of net service revenues was primarily due to more efficient operations for administrative employees for the three months ended March 31, 2024.

Home Health Segment


	For the Three Months Ended March 31,
	2024				2023				Change
	Amount		% of Segment Net Service Revenues		Amount		% of Segment Net Service Revenues		Amount	%
	(Amounts in Thousands, Except Percentages)
Operating Results
Net service revenues	$16,880		100.0	%	$12,485		100.0	%	$4,395	35.2	%
Cost of services revenues	11,066		65.6		7,534		60.3		3,532	46.9
Gross profit	5,814		34.4		4,951		39.7		863	17.4
General and administrative expenses	4,537		26.9		2,879		23.1		1,658	57.6
Segment operating income	$1,277		7.5	%	$2,072		16.6	%	$(795)	(38.4)	%
Business Metrics (Actual Numbers)
Locations at period end	23				13
New admissions * (1)	4,887				3,893				994	25.5	%
Recertifications * (2)	3,168				1,549				1,619	104.5
Total volume * (3)	8,055				5,442				2,613	48.0
Visits * (4)	106,931				77,828				29,103	37.4	%
Organic growth
- Revenue * (5)	(15.1)	%			13.8	%
- Admissions * (5)	(4.0)	%			(3.6)	%

Table of Contents

(1)

Represents new patients during the period.

(2)

A home health certification period is an episode of care that begins with a start of care visit and continues for 60 days. If at the end of the initial episode of care, the patient continues to require home health services, a recertification is required. This represents the number of recertifications during the period.

(3)

Total volume is total admissions and total recertifications in the period.

(4)

Represents number of services to patients in the period.

(5)

Revenue organic growth and admissions organic growth reflect the change in year-over-year revenue and admissions for the same store base. We define the same store base to include those stores open for at least 52 full weeks. These measures highlight the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures.

The home health segment generates net service revenues by providing home health services on a short-term, intermittent or episodic basis to individuals, generally to treat an illness or injury. Net service revenues from Medicare accounted for 69.1% and 74.2%, managed care organizations accounted for 26.1% and 20.3% and other accounted for 4.8% and 5.5% for the three months ended March 31, 2024 and 2023, respectively. Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System, which uses national, standardized 30-day period payment rates for periods of care. CMS uses the PDGM as the case-mix classification model to place periods of care into payment categories, classifying patients based on clinical characteristics. An outlier adjustment may be paid for periods of care in which costs exceed a specific threshold amount.

Net service revenues increased by $4.4 million for the three months ended March 31, 2024, compared to the three months ended March 31, 2023. Total visits increased for the three months ended March 31, 2024, mainly attributed to the acquisition of Tennessee Quality Care on August 1, 2023.

Gross profit, expressed as a percentage of net service revenues, was 34.4% and 39.7% for the three months ended March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024, the decrease was primarily due to an increase in cost of services revenues that more than offset the increase in net service revenues compared to the three months ended March 31, 2023. Cost of services revenues for the three months ended March 31, 2024 increased compared to the corresponding period in 2023 due to an increase in direct employee wage, tax and benefit costs.

The home health segment’s general and administrative expenses primarily consist of administrative employee wage, tax and benefit costs, rent, information technology and office expenses. General and administrative expenses, expressed as a percentage of net service revenues, was 26.9% and 23.1% for the three months ended March 31, 2024 and 2023, respectively. General and administrative expenses for the three months ended March 31, 2024 increased compared to the corresponding period in 2023, primarily due to an increase in administrative employee wage, tax and benefit costs for the three months ended March 31, 2024.

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are cash on hand and cash from operations and borrowings under our credit facility. At March 31, 2024 and December 31, 2023, we had cash balances of $76.7 million and $64.8 million, respectively. At March 31, 2024, we had a $600.0 million revolving credit facility and a $125.0 million incremental loan facility, which may be for term loans or an increase to the revolving loan commitments. The maturity of this credit facility is July 30, 2026.

During the three months ended March 31, 2024, we used $0.4 million in cash to fund the Upstate acquisition and repaid $25.0 million under our revolving credit facility. As of March 31, 2024, we had a total of $101.4 million in revolving loans, with an interest rate of 7.18% outstanding on our credit facility and after giving effect to the amount drawn on our credit facility, approximately $8.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), we had $486.9 million of capacity and $377.5 million available for borrowing under our credit facility. At December 31, 2023, we had a total of $126.4 million revolving credit loans, with an interest rate of 7.21%, outstanding on our credit facility.

Table of Contents

Our credit facility requires us to maintain a total net leverage ratio not exceeding 3.75:1.00. At March 31, 2024, we were in compliance with our financial covenants under the Credit Agreement. Although we believe our liquidity position remains strong, we can provide no assurance that we will remain in compliance with the covenants in our Credit Agreement, and in the future, it may prove necessary to seek an amendment with the bank lending group under our credit facility. Additionally, there can be no assurance that we will be able to raise additional funds on terms acceptable to us, if at all.

See Note 7 to the Notes to Condensed Consolidated Financial Statements, Long-Term Debt, for additional details of our long-term debt.

Current Macroeconomic Conditions and COVID-19 Relief Funding

Economic conditions in the United States continue to be challenging in various respects. For example, the United States economy continues to experience significant inflationary pressures, elevated interest rates and challenging labor market conditions. Any resulting economic downturn would pose a risk to states’ revenues, which in turn could affect our reimbursements and collections received for services rendered. Depending on the severity and length of any potential economic downturn as well as the extent of any federal support, states could face significant fiscal challenges and revise their revenue forecasts and adjust their budgets, and sales tax collections and income tax withholdings could be depressed in fiscal year 2023 (which will end June 30, 2024 in most states), and, potentially, future fiscal years. For example, Illinois, New Mexico and New York, our top three personal care markets, previously revised revenue estimates downward for the 2022 fiscal year as the result of earlier negative economic conditions arising from the COVID-19 pandemic. Also, in response to reduced revenues, the state of New York authorized the issuance of short-term bonds and implemented uniform reductions to Medicaid payments, applicable to home health and personal care services (hospice services were exempt).

ARPA Spending Plans

The ARPA provides for $350 billion in relief funding for eligible state, local, territorial, and Tribal governments to mitigate the fiscal effects of the COVID-19 public health emergency. Additionally, the law provided for a 10 percentage point increase in federal matching funds for Medicaid HCBS from April 1, 2021, through March 31, 2022, provided the state satisfied certain conditions. States are permitted to use the state funds equivalent to the additional federal funds through March 31, 2025. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating

During the three months ended March 31, 2024, the Company received additional state funding provided by the ARPA in an aggregate

Medicare sequester

The CARES Act and related laws temporarily lifted the Medicare sequester, which would have otherwise reduced payments to Medicare providers by 2% as required by the Budget Control Act of 2011, from May 1, 2020, through March 31, 2022. The sequestration payment adjustment was phased back in with a 1% reduction beginning April 1, 2022, and returned to 2% on July 1, 2022. These sequestration cuts have been extended through April 2032.

However, the ARPA increased the federal budget deficit in a manner that triggers an additional statutorily mandated sequestration under the PAYGO Act. As a result, an additional Medicare payment reduction of up to 4% was required to take effect in January 2022. However, Congress has delayed implementation of this payment reduction until 2025. We cannot currently determine if, or to what extent, our business, results of operations, financial condition or liquidity will ultimately be impacted by mandated sequestration triggers under the PAYGO Act, or if or when the mandated sequestration will occur. Further, we anticipate that the federal deficit will continue to place pressure on government healthcare programs, and it is possible that future deficit reduction legislation will impose additional Medicare spending reductions.

Table of Contents

Cash Flows

The following table summarizes changes in our cash flows:


	For the Three Months Ended March 31,
	2024			2023
	(Amounts in Thousands)
Net cash provided by operating activities	$	38,678		$	18,799
Net cash used in investing activities		(1,750	)		(1,742	)
Net cash (used in) provided by financing activities		(25,000	)		(23,475	)

Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023

Cash flows from operating activities represent the inflow of cash from our payors and the outflow of cash for payroll and payroll taxes, operating expenses, interest and taxes. Net cash provided by operating activities was $38.7 million for the three months ended March 31, 2024, compared to net cash used in operating activities of $18.8 million for the same period in 2023. The increase in cash provided by operations was primarily due to the timing of receipts on accounts receivable and the timing of government stimulus funds. The changes in accounts receivable were primarily related to the growth in revenue and a decrease in days sales outstanding (“DSO”) during the three months ended March 31, 2024 as compared to the three months ended March 31, 2023. The related receivables due from the Illinois Department on Aging represented 20.8% and 21.5% of the Company’s net accounts receivable at March 31, 2024 and March 31, 2023, respectively.

Net cash used in investing activities for the three months ended March 31, 2024, primarily consisted of $0.4 million of net cash used for the Upstate acquisition and $1.4 million of cash used for property and equipment purchases, primarily related to our ongoing investments in technology infrastructure fixed assets. Net cash used in investing activities for the three months ended March 31, 2023 primarily consisted of $1.0 million of net cash used for the CareStaff acquisition and $0.7 million of cash used for property and equipment purchases.

Net cash used in financing activities for the three months ended March 31, 2024, primarily consisted of a $25.0 million payment on the revolver portion of our credit facility. Net cash used in financing activities for the three months ended March 31, 2023 primarily consisted of $23.5 million payment on the revolver portion of our credit facility.

Outstanding Accounts Receivable

Gross accounts receivable as of March 31, 2024 and December 31, 2023 were approximately $106.8 million and $117.8 million, respectively. Outstanding accounts receivable, net of allowance for credit losses, decreased by $10.8 million as of March 31, 2024 as compared to December 31, 2023. Accounts receivable for the Illinois Department on Aging decreased approximately $10.6 million during the quarter ended March 31, 2024. Our collection procedures include review of account aging and direct contact with our payors. We have historically not used collection agencies. An uncollectible amount is written off to the allowance account after reasonable collection efforts have been exhausted.

We calculate our DSO by taking the trade accounts receivable outstanding, net of allowance for credit losses for doubtful accounts, divided by the net service revenues for the last quarter, multiplied by the number of days in that quarter. Our DSOs were 35 days and 39 days at March 31, 2024 and December 31, 2023, respectively. The DSOs for our largest payor, the Illinois Department on Aging, were 30 days and 50 days at March 31, 2024 and December 31, 2023, respectively.

Off-Balance Sheet Arrangements

As of March 31, 2024, we did not have any off-balance sheet guarantees or arrangements with unconsolidated entities.

Critical Accounting Policies and Estimates

There have been no material changes to our critical accounting policies and estimates previously disclosed under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” set forth in Part II, Item 7 of our Annual Report on Form 10-K for the period ended December 31, 2023, filed on February 27, 2024.

Recently Issued Accounting Pronouncements

Refer to Note 2 to the Notes to Condensed Consolidated Financial Statements (Unaudited) for further discussion.

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk associated with changes in interest rates on our variable rate long-term debt. As of March 31, 2024, we had outstanding borrowings of approximately $101.4 million on our credit facility, all of such borrowings were subject to variable interest rates. If the variable rates on this debt were 100 basis points higher than the rate applicable to the borrowing during the three month period ended March 31, 2024, our net income would have decreased by $0.2 million, or $0.01 per diluted share. We do not currently have any derivative or hedging arrangements, or other known exposures, to changes in interest rates.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2024. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2024.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the fiscal quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

Legal Proceedings

From time to time, we are subject to legal and/or administrative proceedings incidental to our business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on our financial position and results of operations.

Item 1A. Risk Factors

Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors discussed under the caption “Risk Factors” set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2023, filed on February 27, 2024. There have been no material changes to the risk factors previously disclosed under the caption “Risk Factors” in our Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

Not applicable. Without limiting the generality of the foregoing, during the quarter ended March 31, 2024, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements, as such terms are defined in Item 408(a) of Regulation S-K.

Table of Contents

Item 6. Exhibits

EXHIBIT INDEX


		Incorporated by Reference
Exhibit Number	Description of Document	Form	File No.	Date Filing	Exhibit Number

3.1	Amended and Restated Certificate of Incorporation of the Company dated as of October 27, 2009.	10-Q	001-34504	11/20/2009	3.1

3.2	Amended and Restated Bylaws of the Company, as amended by the First Amendment to the Amended and Restated Bylaws.	10-Q	001-34504	05/9/2013	3.2

4.1	Form of Common Stock Certificate.	S-1	333-160634	10/2/2009	4.1

31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH	Inline XBRL Taxonomy Extension Schema Document.

101.CAL	Inline XBRL Taxonomy Calculation Linkbase Document.

101.LAB	Inline XBRL Taxonomy Label Linkbase Document.

101.PRE	Inline XBRL Presentation Linkbase Document.

101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.

104	Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



	ADDUS HOMECARE CORPORATION

Date: May 7, 2024	By:	/s/ R. DIRK ALLISON

		R. Dirk Allison Chairman and Chief Executive Officer (As Principal Executive Officer)

Date: May 7, 2024	By:	/s/ BRIAN POFF

		Brian Poff Chief Financial Officer (As Principal Financial Officer)

Exhibit 31.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, R. Dirk Allison, certify that:

I have reviewed this quarterly report on Form 10-Q of Addus HomeCare Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: May 7, 2024	By:	/s/ R. Dirk Allison
		R. Dirk Allison
		Chairman and Chief Executive Officer

Exhibit 31.2

CERTIFICATIONS OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Brian Poff, certify that:

I have reviewed this quarterly report on Form 10-Q of Addus HomeCare Corporation;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: May 7, 2024	By:	/s/ Brian Poff
		Brian Poff
		Chief Financial Officer

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

(AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 of Addus HomeCare Corporation (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, R. Dirk Allison, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: May 7, 2024	By:	/s/ R. Dirk Allison
		R. Dirk Allison
		Chairman and Chief Executive Officer

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

(AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 of Addus HomeCare Corporation (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian Poff, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: May 7, 2024	By:	/s/ Brian Poff
		Brian Poff
		Chief Financial Officer

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2024	Apr. 30, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Entity Registrant Name	ADDUS HOMECARE CORPORATION
Entity Central Index Key	0001468328
Trading Symbol	ADUS
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Address, State or Province	TX
Entity File Number	001-34504
Entity Tax Identification Number	20-5340172
Entity Address, Address Line One	6303 Cowboys Way
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	Frisco
Entity Address, Postal Zip Code	75034
City Area Code	469
Local Phone Number	535-8200
Entity Common Stock, Shares Outstanding		16,370,336
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	DE
Title of 12(b) Security	Common Stock, $0.001 par value
Security Exchange Name	NASDAQ

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash	$ 76,719	$ 64,791
Accounts receivable, net of allowances	104,727	115,499
Prepaid expenses and other current assets	10,401	19,714
Total current assets	191,847	200,004
Property and equipment, net of accumulated depreciation and amortization	23,872	24,011
Other assets
Goodwill	663,391	662,995
Intangibles, net of accumulated amortization	90,191	91,983
Operating lease assets, net	44,699	45,433
Total other assets	798,281	800,411
Total assets	1,014,000	1,024,426
Current liabilities
Accounts payable	22,022	26,183
Accrued payroll	44,022	56,551
Accrued expenses	38,772	33,236
Operating lease liabilities, current portion	11,307	11,339
Government stimulus advances	13,548	5,765
Accrued workers' compensation insurance	11,920	12,043
Total current liabilities	141,591	145,117
Long-term liabilities
Long-term debt, less current portion, net of debt issuance costs	99,347	124,132
Long-term operating lease liabilities	39,044	39,711
Other long-term liabilities	8,875	8,772
Total long-term liabilities	147,266	172,615
Total liabilities	288,857	317,732
Stockholders' equity
Common stock-$.001 par value; 40,000 authorized and 16,370 and 16,227 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	16	16
Additional paid-in capital	406,465	403,846
Retained earnings	318,662	302,832
Total stockholders' equity	725,143	706,694
Total liabilities and stockholders' equity	$ 1,014,000	$ 1,024,426

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	16,370,000	16,227,000
Common stock, shares outstanding	16,370,000	16,227,000

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net service revenues	$ 280,746	$ 251,599
Cost of service revenues	192,569	173,184
Gross profit	88,177	78,415
General and administrative expenses	61,063	56,360
Depreciation and amortization	3,469	3,447
Total operating expenses	64,532	59,807
Operating income	23,645	18,608
Interest income	(423)	(106)
Interest expense	2,758	2,461
Total interest expense, net	2,335	2,355
Income before income taxes	21,310	16,253
Income tax expense	5,480	3,578
Net income	$ 15,830	$ 12,675
Net income per common share
Basic income per share	$ 0.99	$ 0.79
Diluted income per share	$ 0.97	$ 0.78
Weighted average number of common shares and potential common shares outstanding:
Basic	16,063	15,949
Diluted	16,373	16,297

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2022	$ 633,540	$ 16	$ 393,208	$ 240,316
Balance, shares at Dec. 31, 2022		16,128
Issuance of shares of common stock under restricted stock award agreements, shares		76
Stock-based compensation	2,646		2,646
Shares issued for exercise of stock options	25		25
Net income	12,675			12,675
Balance at Mar. 31, 2023	648,886	$ 16	395,879	252,991
Balance, shares at Mar. 31, 2023		16,204
Balance at Dec. 31, 2023	706,694	$ 16	403,846	302,832
Balance, shares at Dec. 31, 2023		16,227
Issuance of shares of common stock under restricted stock award agreements, shares		143
Stock-based compensation	2,619		2,619
Net income	15,830			15,830
Balance at Mar. 31, 2024	$ 725,143	$ 16	$ 406,465	$ 318,662
Balance, shares at Mar. 31, 2024		16,370

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 15,830	$ 12,675
Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of acquisitions:
Depreciation and amortization	3,469	3,447
Deferred income taxes	131	(72)
Stock-based compensation	2,619	2,646
Amortization of debt issuance costs under the credit facility	215	215
Provision for credit losses	224	144
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	10,552	85
Prepaid expenses and other current assets	9,331	7,030
Government stimulus advances	7,783	(2,345)
Accounts payable	(4,332)	(494)
Accrued payroll	(12,529)	(10,901)
Accrued expenses and other long-term liabilities	5,385	6,369
Net cash provided by operating activities	38,678	18,799
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(400)	(965)
Purchases of property and equipment	(1,350)	(777)
Net cash used in investing activities	(1,750)	(1,742)
Cash flows from financing activities:
Payments on revolver - credit facility	(25,000)	(23,500)
Cash received from exercise of stock options		25
Net cash (used in) provided by financing activities	(25,000)	(23,475)
Net change in cash	11,928	(6,418)
Cash, at beginning of period	64,791	79,961
Cash, at end of period	76,719	73,543
Supplemental disclosures of cash flow information:
Cash paid for interest	2,527	2,310
Cash paid (refunded) for income taxes	$ 13	$ (39)

Nature of Operations, Consolidation, and Presentation of Financial Statements

3 Months Ended

Mar. 31, 2024

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Nature of Operations, Consolidation, and Presentation of Financial Statements

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Basis of Presentation

Principles of Consolidation

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Estimates

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:


	For the Three Months Ended March 31,
	(Amounts in thousands)
	2024		2023
Weighted average number of shares outstanding for basic per share calculation		16,063		15,949
Effect of dilutive potential shares:
Stock options		227		251
Restricted stock awards		83		97
Adjusted weighted average shares for diluted per share calculation		16,373		16,297
Anti-dilutive shares:
Stock options		61		61
Restricted stock awards		—		—

Recently Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements

Leases

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

Leases

3. Leases

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:


	March 31, 2024		December 31, 2023
	(Amounts in Thousands)
Operating lease assets, net	$	44,699	$	45,433

Short-term operating lease liabilities (in accrued expenses)		11,307		11,339
Long-term operating lease liabilities		39,044		39,711
Total operating lease liabilities	$	50,351	$	51,050

Lease Costs

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:


	For the Three Months Ended March 31, (Amounts in Thousands)
	2024			2023
Operating lease costs	$	3,296		$	3,042
Short-term lease costs		201			416
Total lease costs		3,497			3,458
Less: sublease income		(598	)		(700	)
Total lease costs, net	$	2,899		$	2,758

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:


	March 31, 2024			December 31, 2023
Operating leases:
Weighted average remaining lease term		6.11			6.26
Weighted average discount rate		5.64	%		5.47	%

Maturity of Lease Liabilities

Remaining operating lease payments as of March 31, 2024 were as follows:


	Operating Leases
	(Amounts in Thousands)
Due in the 12-month period ended March 31,
2025	$	10,663
2026		11,299
2027		8,959
2028		6,493
2029		5,496
Thereafter		17,390
Total future minimum rental commitments		60,300
Less: Imputed interest		(9,949	)
Total lease liabilities	$	50,351

Supplemental cash flows information


	For the Three Months Ended March 31,
	(Amounts in Thousands)
	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	3,589	$	3,374

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	2,137	$	10,836

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2024

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

4. Goodwill and Intangible Assets

A summary of the goodwill and related adjustments is provided below:


	Hospice			Personal Care		Home Health		Total
	(Amounts in Thousands)
Goodwill as of December 31, 2023	$	432,799		$	153,276	$	76,920	$	662,995
Additions for acquisition		—			400		—		400
Adjustments to previously recorded goodwill		(54	)		—		50		(4	)
Goodwill as of March 31, 2024	$	432,745		$	153,676	$	76,970	$	663,391

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:


		March 31, 2024							December 31, 2023
		(Amounts in Thousands)							(Amounts in Thousands)
	Estimated Useful Life	Gross carrying value		Accumulated amortization			Net carrying value		Gross carrying value		Accumulated amortization			Net carrying value
Customer and referral relationships	5-10 years	$	44,672	$	(39,907	)	$	4,765	$	44,672	$	(39,566	)	$	5,106
Trade names and trademarks	1-20 years		59,566		(24,608	)		34,958		59,566		(23,857	)		35,709
Non-competition agreement	3-5 years		6,785		(5,805	)		980		6,785		(5,601	)		1,184
State Licenses	6-10 years		12,671		(9,511	)		3,160		12,671		(9,015	)		3,656
State Licenses	Indefinite		46,328		—			46,328		46,328		—			46,328
Total intangible assets		$	170,022	$	(79,831	)	$	90,191	$	170,022	$	(78,039	)	$	91,983

Details of Certain Balance Sheet Accounts

3 Months Ended

Mar. 31, 2024

Details Of Certain Balance Sheet Accounts [Abstract]

Details of Certain Balance Sheet Accounts

5. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:


	March 31, 2024		December 31, 2023
	(Amounts in Thousands)
Prepaid payroll	$	—	$	8,735
Prepaid workers' compensation and liability insurance		2,329		3,696
Prepaid licensing fees		5,651		4,481
Workers' compensation insurance receivable		699		577
Other		1,722		2,225
Total prepaid expenses and other current assets	$	10,401	$	19,714

Accrued expenses consisted of the following:


	March 31, 2024		December 31, 2023
	(Amounts in Thousands)

Accrued health benefits		7,297		7,400
Payor advances (1)		429		1,218
Accrued professional fees		9,112		7,304
Accrued payroll and other taxes		13,013		8,572
Other		8,921		8,742
Total accrued expenses	$	38,772	$	33,236

(1)

Government Actions to Mitigate COVID-19's Impact

3 Months Ended

Mar. 31, 2024

Risks And Uncertainties [Abstract]

Government Actions to Mitigate COVID-19's Impact

6. Government Actions to Mitigate COVID-19’s Impact

ARPA Spending Plans

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating

During the three months ended March 31, 2024, the Company received additional state funding provided by the ARPA in an aggregate

Medicare Sequester

Long-Term Debt

3 Months Ended

Mar. 31, 2024

Long Term Debt [Abstract]

Long-Term Debt

7. Long-Term Debt

Long-term debt consisted of the following:


	March 31, 2024			December 31, 2023
	(Amounts in Thousands)
Revolving loan under the credit facility	$	101,353		$	126,353
Less unamortized issuance costs		(2,006	)		(2,221	)
Long-term debt	$	99,347		$	124,132

Amended and Restated Senior Secured Credit Facility

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility.

During the three months ended March 31, 2024, the Company did not draw on its credit facility and repaid $25.0 million under the revolving credit facility.

As of March 31, 2024, the Company was in compliance with all financial covenants under the Credit Agreement.

Income Taxes

3 Months Ended

Mar. 31, 2024

Income Tax Disclosure [Abstract]

Income Taxes

8. Income Taxes

The effective income tax rates were 25.7% and 22.0% for the three months ended March 31, 2024 and 2023, respectively.

Commitments and Contingencies

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

9. Commitments and Contingencies

Legal Proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business.

Segment Information

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Segment Information

10. Segment Information


	For the Three Months Ended March 31, 2024
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	208,003	$	55,863	$	16,880	$	280,746
Cost of services revenues		152,536		28,967		11,066		192,569
Gross profit		55,467		26,896		5,814		88,177
General and administrative expenses		15,445		13,439		4,537		33,421
Segment operating income	$	40,022	$	13,457	$	1,277		54,756


	For the Three Months Ended March 31, 2023
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	190,032	$	49,082	$	12,485	$	251,599
Cost of services revenues		138,383		27,267		7,534		173,184
Gross profit		51,649		21,815		4,951		78,415
General and administrative expenses		15,935		13,015		2,879		31,829
Segment operating income	$	35,714	$	8,800	$	2,072	$	46,586


	For the Three Months Ended March 31,
	2024			2023
	(Amounts in Thousands)
Segment reconciliation:
Total segment operating income	$	54,756		$	46,586

Items not allocated at segment level:
Other general and administrative expenses		27,642			24,531
Depreciation and amortization		3,469			3,447
Interest income		(423	)		(106	)
Interest expense		2,758			2,461
Income before income taxes	$	21,310		$	16,253

Significant Payors

3 Months Ended

Mar. 31, 2024

Significant Payors [Abstract]

Significant Payors

11. Significant Payors

The Company’s revenue by payor type was as follows:



Personal Care Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
State, local and other governmental programs	$107,754	51.8	%	$95,320	50.1	%
Managed care organizations	94,276	45.3		87,901	46.3
Private pay	3,906	1.9		4,226	2.2
Commercial insurance	1,486	0.7		1,669	0.9
Other	581	0.3		916	0.5
Total personal care segment net service revenues	$208,003	100.0	%	$190,032	100.0	%



Hospice Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Medicare	$50,652	90.7	%	$44,556	90.7	%
Commercial insurance	3,134	5.6		2,547	5.2
Managed care organizations	1,817	3.3		1,647	3.4
Other	260	0.4		332	0.7
Total hospice segment net service revenues	$55,863	100.0	%	$49,082	100.0	%



Home Health Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Medicare	$11,663	69.1	%	$9,270	74.2	%
Managed care organizations	4,400	26.1		2,539	20.3
Other	817	4.8		676	5.5
Total home health segment net service revenues	$16,880	100.0	%	$12,485	100.0	%



Personal Care Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Illinois	$107,575	51.8	%	$98,414	51.8	%
New Mexico	28,967	13.9		28,474	15.0
New York(1)	23,534	11.3		21,885	11.5
All other states	47,927	23.0		41,259	21.7
Total personal care segment net service revenues	$208,003	100.0	%	$190,032	100.0	%

(1)



Hospice Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Ohio	$20,236	36.2	%	$18,451	37.6	%
Illinois	12,252	21.9		11,480	23.4
New Mexico	7,515	13.5		6,486	13.2
All other states	15,860	28.4		12,665	25.8
Total hospice segment net service revenues	$55,863	100.0	%	$49,082	100.0	%



Home Health Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
New Mexico	$7,777	46.1	%	$9,116	73.0	%
Illinois	2,942	17.4		3,369	27.0
Tennessee	6,161	36.5		—	—
Total home health segment net service revenues	$16,880	100.0	%	$12,485	100.0	%

The related receivables due from the Illinois Department on Aging represented 18.0% and 20.7% of the Company’s net accounts receivable at March 31, 2024 and December 31, 2023, respectively.

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Basis of Presentation

Principles of Consolidation

Estimates

Computation of Weighted Average Shares

The following table sets forth the computation of basic and diluted common shares:


	For the Three Months Ended March 31,
	(Amounts in thousands)
	2024		2023
Weighted average number of shares outstanding for basic per share calculation		16,063		15,949
Effect of dilutive potential shares:
Stock options		227		251
Restricted stock awards		83		97
Adjusted weighted average shares for diluted per share calculation		16,373		16,297
Anti-dilutive shares:
Stock options		61		61
Restricted stock awards		—		—

Recently Issued and Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Computation of Basic and Diluted Common Shares

The following table sets forth the computation of basic and diluted common shares:


	For the Three Months Ended March 31,
	(Amounts in thousands)
	2024		2023
Weighted average number of shares outstanding for basic per share calculation		16,063		15,949
Effect of dilutive potential shares:
Stock options		227		251
Restricted stock awards		83		97
Adjusted weighted average shares for diluted per share calculation		16,373		16,297
Anti-dilutive shares:
Stock options		61		61
Restricted stock awards		—		—

Leases (Tables)

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

Amounts Reported in Unaudited and Audited Condensed Consolidated Balance Sheets for Operating Leases

Amounts reported on the Company’s Unaudited Condensed Consolidated Balance Sheets for operating leases were as follows:


	March 31, 2024		December 31, 2023
	(Amounts in Thousands)
Operating lease assets, net	$	44,699	$	45,433

Short-term operating lease liabilities (in accrued expenses)		11,307		11,339
Long-term operating lease liabilities		39,044		39,711
Total operating lease liabilities	$	50,351	$	51,050

Components of Lease Costs Reported in General and Administrative Expenses in Unaudited Condensed Consolidated Statements of Income

Components of lease costs were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:


	For the Three Months Ended March 31, (Amounts in Thousands)
	2024			2023
Operating lease costs	$	3,296		$	3,042
Short-term lease costs		201			416
Total lease costs		3,497			3,458
Less: sublease income		(598	)		(700	)
Total lease costs, net	$	2,899		$	2,758

Schedule of Weighted Average Remaining Lease Terms and Discount Rates

Weighted average remaining lease terms and discount rates were as follows:


	March 31, 2024			December 31, 2023
Operating leases:
Weighted average remaining lease term		6.11			6.26
Weighted average discount rate		5.64	%		5.47	%

Summary of Remaining Operating Lease Payments

Remaining operating lease payments as of March 31, 2024 were as follows:


	Operating Leases
	(Amounts in Thousands)
Due in the 12-month period ended March 31,
2025	$	10,663
2026		11,299
2027		8,959
2028		6,493
2029		5,496
Thereafter		17,390
Total future minimum rental commitments		60,300
Less: Imputed interest		(9,949	)
Total lease liabilities	$	50,351

Supplemental Cash Flows Information


	For the Three Months Ended March 31,
	(Amounts in Thousands)
	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	3,589	$	3,374

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	2,137	$	10,836

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2024

Goodwill And Intangible Assets Disclosure [Abstract]

Summary of Goodwill and Related Adjustments

A summary of the goodwill and related adjustments is provided below:


	Hospice			Personal Care		Home Health		Total
	(Amounts in Thousands)
Goodwill as of December 31, 2023	$	432,799		$	153,276	$	76,920	$	662,995
Additions for acquisition		—			400		—		400
Adjustments to previously recorded goodwill		(54	)		—		50		(4	)
Goodwill as of March 31, 2024	$	432,745		$	153,676	$	76,970	$	663,391

Schedule of Carrying Amount and Accumulated Amortization of Intangible Asset

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following:


		March 31, 2024							December 31, 2023
		(Amounts in Thousands)							(Amounts in Thousands)
	Estimated Useful Life	Gross carrying value		Accumulated amortization			Net carrying value		Gross carrying value		Accumulated amortization			Net carrying value
Customer and referral relationships	5-10 years	$	44,672	$	(39,907	)	$	4,765	$	44,672	$	(39,566	)	$	5,106
Trade names and trademarks	1-20 years		59,566		(24,608	)		34,958		59,566		(23,857	)		35,709
Non-competition agreement	3-5 years		6,785		(5,805	)		980		6,785		(5,601	)		1,184
State Licenses	6-10 years		12,671		(9,511	)		3,160		12,671		(9,015	)		3,656
State Licenses	Indefinite		46,328		—			46,328		46,328		—			46,328
Total intangible assets		$	170,022	$	(79,831	)	$	90,191	$	170,022	$	(78,039	)	$	91,983

Details of Certain Balance Sheet Accounts (Tables)

3 Months Ended

Mar. 31, 2024

Details Of Certain Balance Sheet Accounts [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following:


	March 31, 2024		December 31, 2023
	(Amounts in Thousands)
Prepaid payroll	$	—	$	8,735
Prepaid workers' compensation and liability insurance		2,329		3,696
Prepaid licensing fees		5,651		4,481
Workers' compensation insurance receivable		699		577
Other		1,722		2,225
Total prepaid expenses and other current assets	$	10,401	$	19,714

Schedule of Accrued Expenses

Accrued expenses consisted of the following:


	March 31, 2024		December 31, 2023
	(Amounts in Thousands)

Accrued health benefits		7,297		7,400
Payor advances (1)		429		1,218
Accrued professional fees		9,112		7,304
Accrued payroll and other taxes		13,013		8,572
Other		8,921		8,742
Total accrued expenses	$	38,772	$	33,236

(1)

Long-Term Debt (Tables)

3 Months Ended

Mar. 31, 2024

Long Term Debt [Abstract]

Schedule of Long-Term Debt

Long-term debt consisted of the following:


	March 31, 2024			December 31, 2023
	(Amounts in Thousands)
Revolving loan under the credit facility	$	101,353		$	126,353
Less unamortized issuance costs		(2,006	)		(2,221	)
Long-term debt	$	99,347		$	124,132

Segment Information (Tables)

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Summary of Segment Information


	For the Three Months Ended March 31, 2024
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	208,003	$	55,863	$	16,880	$	280,746
Cost of services revenues		152,536		28,967		11,066		192,569
Gross profit		55,467		26,896		5,814		88,177
General and administrative expenses		15,445		13,439		4,537		33,421
Segment operating income	$	40,022	$	13,457	$	1,277		54,756


	For the Three Months Ended March 31, 2023
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	190,032	$	49,082	$	12,485	$	251,599
Cost of services revenues		138,383		27,267		7,534		173,184
Gross profit		51,649		21,815		4,951		78,415
General and administrative expenses		15,935		13,015		2,879		31,829
Segment operating income	$	35,714	$	8,800	$	2,072	$	46,586


	For the Three Months Ended March 31,
	2024			2023
	(Amounts in Thousands)
Segment reconciliation:
Total segment operating income	$	54,756		$	46,586

Items not allocated at segment level:
Other general and administrative expenses		27,642			24,531
Depreciation and amortization		3,469			3,447
Interest income		(423	)		(106	)
Interest expense		2,758			2,461
Income before income taxes	$	21,310		$	16,253

Significant Payors (Tables)

3 Months Ended

Mar. 31, 2024

Significant Payors [Abstract]

Schedule of Revenue by Payor Type

The Company’s revenue by payor type was as follows:



Personal Care Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
State, local and other governmental programs	$107,754	51.8	%	$95,320	50.1	%
Managed care organizations	94,276	45.3		87,901	46.3
Private pay	3,906	1.9		4,226	2.2
Commercial insurance	1,486	0.7		1,669	0.9
Other	581	0.3		916	0.5
Total personal care segment net service revenues	$208,003	100.0	%	$190,032	100.0	%



Hospice Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Medicare	$50,652	90.7	%	$44,556	90.7	%
Commercial insurance	3,134	5.6		2,547	5.2
Managed care organizations	1,817	3.3		1,647	3.4
Other	260	0.4		332	0.7
Total hospice segment net service revenues	$55,863	100.0	%	$49,082	100.0	%



Home Health Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Medicare	$11,663	69.1	%	$9,270	74.2	%
Managed care organizations	4,400	26.1		2,539	20.3
Other	817	4.8		676	5.5
Total home health segment net service revenues	$16,880	100.0	%	$12,485	100.0	%

Schedule of Revenue by Geographic Location

The percentages of segment revenue for each of these significant states were as follows:



Personal Care Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Illinois	$107,575	51.8	%	$98,414	51.8	%
New Mexico	28,967	13.9		28,474	15.0
New York(1)	23,534	11.3		21,885	11.5
All other states	47,927	23.0		41,259	21.7
Total personal care segment net service revenues	$208,003	100.0	%	$190,032	100.0	%

(1)



Hospice Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
Ohio	$20,236	36.2	%	$18,451	37.6	%
Illinois	12,252	21.9		11,480	23.4
New Mexico	7,515	13.5		6,486	13.2
All other states	15,860	28.4		12,665	25.8
Total hospice segment net service revenues	$55,863	100.0	%	$49,082	100.0	%



Home Health Segment	For the Three Months Ended March 31,
	2024			2023
	Amount (in Thousands)	% of Segment Net Service Revenues		Amount (in Thousands)	% of Segment Net Service Revenues
New Mexico	$7,777	46.1	%	$9,116	73.0	%
Illinois	2,942	17.4		3,369	27.0
Tennessee	6,161	36.5		—	—
Total home health segment net service revenues	$16,880	100.0	%	$12,485	100.0	%

Nature of Operations, Consolidation, and Presentation of Financial Statements (Narrative) (Details)	3 Months Ended
	Mar. 31, 2024 Segment
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Number of operating segments	3

Summary of Significant Accounting Policies (Computation of Basic and Diluted Common Shares) (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Summary Of Significant Accounting Policies [Line Items]
Weighted average number of shares outstanding for basic per share calculation	16,063	15,949
Effect of dilutive potential shares:
Adjusted weighted average shares for diluted per share calculation	16,373	16,297
Stock Options [Member]
Effect of dilutive potential shares:
Effect of dilutive potential shares	227	251
Anti-dilutive shares:
Anti-dilutive shares	61	61
Restricted Stock Awards [Member]
Effect of dilutive potential shares:
Effect of dilutive potential shares	83	97

Summary of Significant Accounting Policies (Narrative) (Details)	Mar. 31, 2024
ASU 2021-08 [Member]
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, adopted	true
Change in accounting principle, accounting standards update, immaterial effect	true
Change in accounting principle, accounting standards update, adoption date	Jan. 01, 2023
Accounting Standards Update 2023-07 [Member]
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, early adoption	true
Accounting Standards Update 2023-09 [Member]
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, immaterial effect	true
Change in accounting principle, accounting standards update, early adoption	true

Leases (Amounts Reported in Unaudited and Audited Condensed Consolidated Balance Sheets for Operating Leases) (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Operating lease assets, net	$ 44,699	$ 45,433
Short-term operating lease liabilities (in accrued expenses)	$ 11,307	$ 11,339
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses	Accrued expenses
Long-term operating lease liabilities	$ 39,044	$ 39,711
Total operating lease liabilities	$ 50,351	$ 51,050

Leases (Components of Lease Costs Reported in General and Administrative Expenses in Unaudited Condensed Consolidated Statements of Income) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Leases [Abstract]
Operating lease costs	$ 3,296	$ 3,042
Short-term lease costs	201	416
Total lease costs	3,497	3,458
Less: sublease income	(598)	(700)
Total lease costs, net	$ 2,899	$ 2,758

Leases (Schedule of Weighted Average Remaining Lease Terms and Discount Rates) (Details)	Mar. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Weighted average remaining lease term	6 years 1 month 9 days	6 years 3 months 3 days
Weighted average discount rate	5.64%	5.47%

Leases (Summary of Remaining Operating Lease Payments) (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Leases [Abstract]
2025	$ 10,663
2026	11,299
2027	8,959
2028	6,493
2029	5,496
Thereafter	17,390
Total future minimum rental commitments	60,300
Less: Imputed interest	(9,949)
Total lease liabilities	$ 50,351	$ 51,050

Leases (Supplemental Cash Flows Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 3,589	$ 3,374
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 2,137	$ 10,836

Goodwill and Intangible Assets (Summary of Goodwill and Related Adjustments) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Goodwill [Line Items]
Goodwill, at Beginning of Period	$ 662,995
Additions for acquisitions	400
Adjustments to previously recorded goodwill	(4)
Goodwill, at End of Period	663,391
Hospice [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	432,799
Adjustments to previously recorded goodwill	(54)
Goodwill, at End of Period	432,745
Personal Care [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	153,276
Additions for acquisitions	400
Goodwill, at End of Period	153,676
Home Health [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	76,920
Adjustments to previously recorded goodwill	50
Goodwill, at End of Period	$ 76,970

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Thousands		3 Months Ended
	Mar. 09, 2024	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Goodwill [Line Items]
Goodwill		$ 663,391		$ 662,995
Total purchase price for business acquisition		400	$ 965
Amortization expense		$ 1,800	$ 1,700
Weighted average remaining useful lives of identifiable intangible assets		10 years 1 month 20 days
Minimum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives		1 year
Minimum [Member] \| Customer and Referral Relationships [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives		5 years
Maximum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives		20 years
Maximum [Member] \| Customer and Referral Relationships [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives		10 years
Personal Care [Member]
Goodwill [Line Items]
Goodwill		$ 153,676		$ 153,276
Upstate Home Care Solutions [Member]
Goodwill [Line Items]
Total purchase price for business acquisition	$ 400
Upstate Home Care Solutions [Member] \| Personal Care [Member]
Goodwill [Line Items]
Goodwill		$ 400

Goodwill and Intangible Assets (Schedule of Carrying Amount and Accumulated Amortization of Intangible Asset) (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Intangible assets subject to amortization:
Accumulated amortization	$ (79,831)	$ (78,039)
Total intangible assets, Gross carrying value	170,022	170,022
Total intangible assets, Net carrying value	$ 90,191	91,983
Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	1 year
Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	20 years
Customer and Referral Relationships [Member]
Intangible assets subject to amortization:
Gross carrying value	$ 44,672	44,672
Accumulated amortization	(39,907)	(39,566)
Net carrying value	$ 4,765	5,106
Customer and Referral Relationships [Member] \| Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	5 years
Customer and Referral Relationships [Member] \| Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	10 years
Trade Names and Trademarks [Member]
Intangible assets subject to amortization:
Gross carrying value	$ 59,566	59,566
Accumulated amortization	(24,608)	(23,857)
Net carrying value	$ 34,958	35,709
Trade Names and Trademarks [Member] \| Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	1 year
Trade Names and Trademarks [Member] \| Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	20 years
Non-competition Agreements [Member]
Intangible assets subject to amortization:
Gross carrying value	$ 6,785	6,785
Accumulated amortization	(5,805)	(5,601)
Net carrying value	$ 980	1,184
Non-competition Agreements [Member] \| Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	3 years
Non-competition Agreements [Member] \| Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	5 years
State Licenses [Member]
Intangible assets subject to amortization:
Gross carrying value	$ 12,671	12,671
Accumulated amortization	(9,511)	(9,015)
Net carrying value	3,160	3,656
Indefinite-Lived Intangible Assets (Excluding Goodwill)	$ 46,328	$ 46,328
State Licenses [Member] \| Minimum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	6 years
State Licenses [Member] \| Maximum [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets, estimated useful lives	10 years

Details of Certain Balance Sheet Accounts (Schedule of Prepaid Expenses and Other Current Assets) (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Details Of Certain Balance Sheet Accounts [Abstract]
Prepaid payroll		$ 8,735
Prepaid workers' compensation and liability insurance	$ 2,329	3,696
Prepaid licensing fees	5,651	4,481
Workers' compensation insurance receivable	699	577
Other	1,722	2,225
Total prepaid expenses and other current assets	$ 10,401	$ 19,714

Details of Certain Balance Sheet Accounts (Schedule of Accrued Expenses) (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Details Of Certain Balance Sheet Accounts [Abstract]
Accrued health benefits	$ 7,297	$ 7,400
Payor advances	429	1,218
Accrued professional fees	9,112	7,304
Accrued payroll and other taxes	13,013	8,572
Other	8,921	8,742
Total accrued expenses	$ 38,772	$ 33,236

Government Actions to Mitigate COVID-19's Impact (Narrative) (Details) - USD ($)			1 Months Ended	3 Months Ended		12 Months Ended
	Jul. 01, 2022	Mar. 11, 2021	Jan. 31, 2022	Mar. 31, 2024	Jun. 30, 2022	Mar. 31, 2022
CARES Act [Member]
Government Assistance [Line Items]
Percentage of reduced payments to Medicare providers	2.00%			2.00%
Reduction percentage on sequestration adjustment					1.00%
ARPA [Member]
Government Assistance [Line Items]
Relief funding to mitigate fiscal effects of COVID-19		$ 350,000,000,000
percentage point increase in federal matching funds						10.00%
Deferred portion of spending plans				$ 13,500,000
Aggregate principal amount of grants received				10,200,000
Fund distributed to primarily for caregivers and retention efforts				2,400,000
Revenues				0
Cost of revenue				0
Aggregate funding amount				$ 10,200,000
PAYGO Act [Member]
Government Assistance [Line Items]
Percentage of additional payment reduction			4.00%

Long-Term Debt (Schedule of Long-Term Debt) (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Less unamortized issuance costs	$ (2,006)	$ (2,221)
Long-term debt	99,347	124,132
Revolving Credit Loan [Member] \| Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt gross	$ 101,353	$ 126,353

Long-Term Debt (Narrative) (Details) - Credit Agreement [Member] - USD ($)		3 Months Ended
	Apr. 26, 2023	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Line of credit outstanding amount		$ 486,900,000
Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available		377,500,000
Debt instrument, maturity date	Jul. 30, 2026
Debt instrument variable interest rate margin	1.00%
Debt instrument total net leverage ratio	4.25%
Line of credit outstanding amount		8,000,000.0
Capital One, National Association [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument total net leverage ratio	3.75%
Capital One, National Association [Member] \| Federal Funds Rate [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	0.50%
Capital One, National Association [Member] \| One-Month Secured Overnight Financing Rate (SOFR) [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	0.10%
Capital One, National Association [Member] \| One-Month Secured Overnight Financing Rate (SOFR) [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	0.00%
Capital One, National Association [Member] \| Based On Applicable Senior Leverage Ratio [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	0.75%
Capital One, National Association [Member] \| Based On Applicable Senior Leverage Ratio [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	1.50%
Capital One, National Association [Member] \| Based On Applicable Leverage Ratio [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	1.75%
Capital One, National Association [Member] \| Based On Applicable Leverage Ratio [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin	2.50%
Capital One, National Association [Member] \| Restriction on Dividends [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Aggregate amount of dividends and distributions		7,500,000
Revolving Credit Loan [Member] \| Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available		600,000,000
Proceeds from line of credit		0
Repayments of line of credit		25,000,000
Line of credit outstanding amount		$ 101,400,000	$ 126,400,000
Debt instrument stated interest rate		7.18%	7.21%
Revolving Credit Loan [Member] \| Capital One, National Association [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Fee charged on unused portion of revolving credit facility		0.20%
Revolving Credit Loan [Member] \| Capital One, National Association [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Fee charged on unused portion of revolving credit facility		0.35%
Incremental Loan Facility [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available		$ 125,000,000

Income Taxes (Narrative) (Details)	3 Months Ended
Income Taxes (Narrative) (Details)	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	25.70%	22.00%
Percentage of excess tax (benefit) expense included in effective income tax rate	0.10%	1.20%

Segment Information (Narrative) (Details)	3 Months Ended
Segment Information (Narrative) (Details)	Mar. 31, 2024 Segment
Segment Reporting [Abstract]
Number of business segments	3

Segment Information (Summary of Segment Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Net service revenues	$ 280,746	$ 251,599
Cost of services revenues	192,569	173,184
Gross profit	88,177	78,415
General and administrative expenses	61,063	56,360
Operating income	23,645	18,608
Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	33,421	31,829
Operating income	54,756	46,586
Personal Care [Member]
Segment Reporting Information [Line Items]
Net service revenues	208,003	190,032
Cost of services revenues	152,536	138,383
Gross profit	55,467	51,649
Personal Care [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	15,445	15,935
Operating income	40,022	35,714
Hospice [Member]
Segment Reporting Information [Line Items]
Net service revenues	55,863	49,082
Cost of services revenues	28,967	27,267
Gross profit	26,896	21,815
Hospice [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	13,439	13,015
Operating income	13,457	8,800
Home Health [Member]
Segment Reporting Information [Line Items]
Net service revenues	16,880	12,485
Cost of services revenues	11,066	7,534
Gross profit	5,814	4,951
Home Health [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses	4,537	2,879
Operating income	$ 1,277	$ 2,072

Segment Information (Segment Reconciliation to Totals reported in the accompanying Consolidated Financial Statements) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Operating income	$ 23,645	$ 18,608
Other general and administrative expenses	27,642	24,531
Depreciation and amortization	3,469	3,447
Interest income	(423)	(106)
Interest expense	2,758	2,461
Income before income taxes	21,310	16,253
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating income	$ 54,756	$ 46,586

Significant Payors (Revenue by Payor Type) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net service revenues	$ 280,746	$ 251,599
Personal Care [Member]
Net service revenues	208,003	190,032
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues	$ 208,003	$ 190,032
Concentration risk, percentage	100.00%	100.00%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| State, Local And Other Governmental Programs [Member]
Net service revenues	$ 107,754	$ 95,320
Concentration risk, percentage	51.80%	50.10%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues	$ 94,276	$ 87,901
Concentration risk, percentage	45.30%	46.30%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Private Pay [Member]
Net service revenues	$ 3,906	$ 4,226
Concentration risk, percentage	1.90%	2.20%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Commercial Insurance [Member]
Net service revenues	$ 1,486	$ 1,669
Concentration risk, percentage	0.70%	0.90%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues	$ 581	$ 916
Concentration risk, percentage	0.30%	0.50%
Hospice [Member]
Net service revenues	$ 55,863	$ 49,082
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues	$ 55,863	$ 49,082
Concentration risk, percentage	100.00%	100.00%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Medicare [Member]
Net service revenues	$ 50,652	$ 44,556
Concentration risk, percentage	90.70%	90.70%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues	$ 1,817	$ 1,647
Concentration risk, percentage	3.30%	3.40%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Commercial Insurance [Member]
Net service revenues	$ 3,134	$ 2,547
Concentration risk, percentage	5.60%	5.20%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues	$ 260	$ 332
Concentration risk, percentage	0.40%	0.70%
Home Health [Member]
Net service revenues	$ 16,880	$ 12,485
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues	$ 16,880	$ 12,485
Concentration risk, percentage	100.00%	100.00%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Medicare [Member]
Net service revenues	$ 11,663	$ 9,270
Concentration risk, percentage	69.10%	74.20%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues	$ 4,400	$ 2,539
Concentration risk, percentage	26.10%	20.30%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues	$ 817	$ 676
Concentration risk, percentage	4.80%	5.50%

Significant Payors (Revenue by Geographic Location) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net service revenues	$ 280,746	$ 251,599
Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Concentration risk, percentage	38.30%	39.10%
Personal Care [Member]
Net service revenues	$ 208,003	$ 190,032
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues	$ 208,003	$ 190,032
Concentration risk, percentage	100.00%	100.00%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Net service revenues	$ 107,575	$ 98,414
Concentration risk, percentage	51.80%	51.80%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues	$ 28,967	$ 28,474
Concentration risk, percentage	13.90%	15.00%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New York [Member]
Net service revenues	$ 23,534	$ 21,885
Concentration risk, percentage	11.30%	11.50%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| All Other States [Member]
Net service revenues	$ 47,927	$ 41,259
Concentration risk, percentage	23.00%	21.70%
Hospice [Member]
Net service revenues	$ 55,863	$ 49,082
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues	$ 55,863	$ 49,082
Concentration risk, percentage	100.00%	100.00%
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| Ohio [Member]
Net service revenues	$ 20,236	$ 18,451
Concentration risk, percentage	36.20%	37.60%
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Net service revenues	$ 12,252	$ 11,480
Concentration risk, percentage	21.90%	23.40%
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues	$ 7,515	$ 6,486
Concentration risk, percentage	13.50%	13.20%
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| All Other States [Member]
Net service revenues	$ 15,860	$ 12,665
Concentration risk, percentage	28.40%	25.80%
Home Health [Member]
Net service revenues	$ 16,880	$ 12,485
Home Health [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues	$ 16,880	$ 12,485
Concentration risk, percentage	100.00%	100.00%
Home Health [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Net service revenues	$ 2,942	$ 3,369
Concentration risk, percentage	17.40%	27.00%
Home Health [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| Tennessee [Member]
Net service revenues	$ 6,161
Concentration risk, percentage	36.50%
Home Health [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues	$ 7,777	$ 9,116
Concentration risk, percentage	46.10%	73.00%

Significant Payors (Narrative) (Details) - Illinois [Member]	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Revenues [Member] \| Illinois Department On Aging [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	20.80%	21.50%
Revenues [Member] \| Geographic Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	38.30%	39.10%
Accounts Receivable [Member] \| Illinois Department On Aging [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	18.00%		20.70%

Grafico Azioni Addus HomeCare (NASDAQ:ADUS)
Storico
Da Nov 2024 a Dic 2024

Clicca qui per i Grafici di Addus HomeCare

Grafico Azioni Addus HomeCare (NASDAQ:ADUS)
Storico
Da Dic 2023 a Dic 2024

Large Accelerated Filer

Accelerated Filer

Non-Accelerated Filer

Smaller Reporting Company

Emerging Growth Company